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Abstract 
Cells respond to mechanical stimuli in their environment as shown by changes in 
phenotype, proliferation, and alignment.  The most prominent cells in the aortic valve, 
valvular interstitial cells, differentiate into a more contractile phenotype if maintenance of 
the valve becomes uncontrolled.  The resulting stiffening of the tissue leads to 
pathological conditions in heart valves that warrant the need for repair or replacement.  
To study the effects of mechanical stimuli on cells, we have developed a method to 
stretch cultured cells equibiaxially at various levels on substrates of controlled stiffness.  
A commercially available device that utilizes vacuum pressure was used to stretch the 
latex membrane (0-20%) of custom culture plates over a near-frictionless platen.  
Polyacrylamide (PA) was covalently bonded to the membrane through polymerization.  A 
second layer of PA was then polymerized on top of the primary substrate for the purpose 
of stiffness adjustment and obtaining a smooth cell interaction layer.  Stiffness levels of 
the cell interaction layers were adjusted (7-75kPa) by altering the ratio of acrylamide to 
bis-acrylamide.  Image analysis was used to validate the stretch of the latex membrane 
using the triad method.  The homogeneity of the strain fields applied to the 
polyacrylamide substrates, and thus the cells, was verified using high density mapping.  
Functionality and cell viability were verified and measurements of mechanical stimuli 
were then validated. This method will be applied in future research to study VIC 
mechanobiology – knowledge from these studies will improve heart valve treatment 
options and aid in the design of biologically active replacements. 
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Chapter 1:  Introduction 
Valvular heart disease results in approximately 275,000 valve replacement 
procedures performed annually worldwide (Vesely,2004).  Structural deterioration, 
calcification, tissue overgrowth, and thromboembolism frequently lead to abnormal tissue 
stiffness levels that contribute to the mechanical failure of heart valves (Merryman et al., 
2006; Simionescu,2006).  While many treatment alternatives exist, understanding the 
factors that regulate the activity of heart valve cells is critical for circumventing 
pathological heart valve fibrosis (Walker et al., 2004) and engineering improved 
biologically active heart valve replacements (Hoerstrup et al., 2002; Weston et al., 2001). 
Researchers postulate that the abnormal stiffness in diseased valve leaflets is 
caused by the unregulated differentiation of valvular interstitial cells (VICs) into a 
contractile phenotype (myofibroblasts) (Walker et al., 2004).  VICs, the most prominent 
cell type in heart valves, are responsible for maintaining structural integrity of the 
leaflets. In heavily loaded areas, where the extracellular matrix (ECM) becomes 
damaged, VICs differentiate into myofibroblasts to aid in rapid matrix repair and 
remodeling of the leaflet (Rabkin-Aikawa et al., 2004).  An increased level of 
myofibroblasts, due to inadequate apoptosis or excessive differentiation, results in the 
stiffening of leaflet tissue (Walker et al., 2004).  Myofibroblast differentiation is known 
to be stimulated by elevated stiffness of the cell surroundings (Rabkin et al., 2002; Turina 
et al., 1993) and external loading (Tomasek et al., 2002).  However, the combination of 
these factors in their native environment is not well understood (Masters et al., 2004b). 
In vitro, studies have shown that many cell types, including VICs, respond to 
mechanical stimuli.  For instance, cells preferentially attach to stiff substrates compared 
to compliant substrates and migrate toward (Lo et al., 2000) and remain on the stiff 
substrates (Gray et al., 2003).  Separate studies have shown increased strains causing 
cells to remodel the ECM through increased collagen synthesis and release of growth 
factors (Butt et al., 1997; Ku et al., 2006; Neidlinger-Wilke et al., 1994).  Simultaneously 
applying controlled stiffness and stretch to the cellular environment would be a better 
technique for mimicking heart valve physiology to study cellular response.  However, 
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there is currently no method available for studying the combined effects of these 
mechanical parameters. 
In this project, we present a method to study the extent of the combined effects of 
controlled levels of stiffness and stretch on cell response.  Using a cyclic equibiaxial 
stretch device with a stretchable membrane, strains similar to in vivo conditions are 
applied.  The attachment of a substrate with modifiable stiffness levels to the stretch 
device membrane allows the effects of both normal and diseased valve conditions to be 
simulated.  This method will be the first to apply controlled stiffness and stretch 
simultaneously to a cellular environment, which more accurately models in vivo 
conditions than previous studies.  This method will be applied in future research to study 
VIC mechanobiology under normal and pathological conditions.  Knowledge from these 
studies will improve heart valve treatment options and aid in the design of biologically 
active replacements. 
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Chapter 2:  Background 
Cardiac dysfunction is the cause of 750,000 deaths annually in the United States 
(Yost et al., 2004).  This is approximately twice the number of deaths each year resulting 
from all types of cancer.  The American Heart Association reported 48,297 deaths in 
2003 from the direct or underlying effects of valvular disease.  Roughly 80% of these 
cases were specific to the morbidity of the aortic valve (Thom et al., 2006).  While the 
cause of valvular disease is not completely understood, most forms result from either 
calcification or mechanical degradation of the leaflets.  This leads to stenosis, 
degeneration, or regurgitation of the valve through either stiffening or loss of structural 
integrity.  The impaired function of the valve increases workload on the heart to maintain 
physiological demands (Vesely,2004). 
Current treatment of diseased valves involves replacement with either a 
bioprosthetic or artificial valve (Vesely,2004).  Failure of these replacements requires the 
need for improved heart valve treatment options (Simionescu,2006; Vesely,2004; 
Yoganathan et al., 2004).  Understanding the response of each cell type to its mechanical 
environment and the signals that trigger repair in normal and diseased states is 
imperative.  Our project involves the development of a method to study the effects of 
mechanical stimuli contributing to these responses.  This section contains supportive 
information for identifying our final method in successive chapters. 
 
2.1  Heart Valve Anatomy and Physiology 
 
Each of the heart’s four valves maintains unidirectional and non-obstructed blood 
flow in response to pressure changes during normal cardiac cycle.  The average healthy 
heart cycle is 75 beats per minute (bpm) at rest and up to 150 bpm during exercise 
(Tortora et al., 2003).  With every heartbeat, each valve endures continuous mechanical 
forces, such as cyclic stress.  When a valve fails mechanically due to disease, 
replacement is necessary.  The aortic valve most frequently warrants the need for repair 
or replacement of pathological leaflets (Merryman et al., 2006). 
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2.1.1 Normal Leaflet Physiology 
The physiological composition of a human heart valve is optimized for response 
to pressure changes during diastole and systole stages of the cardiac cycle.  The aortic 
valve is tricuspid, with the three heterogeneous leaflets attached to an annular ring.  
These leaflets open during forward flow (systole) and close rapidly upon slight 
backpressure (diastole) to maintain efficient unidirectional flow with each heart beat 
(Fong et al., 2006).  Valve leaflets consist of three layers of tissue that together have the 
necessary biomechanical properties to withstand cyclic loading.  The composition and 
function of each layer is shown in Table 1. 
 
Table 1:  Composition and function of each valve layer 
Layer Composition Function 
Top Fibrosa Endothelial cells, densely packed collagen 
Maintain durability and 
stiffness to undergo 80 mmHg 
pressure gradient 
Middle Spongiosa 
VICs, loosely arranged 
collagen, elastin, 
glycosaminoglycans 
Allows shearing between the 
ventricularis and the fibrosa 
during valve cycle 
Bottom Ventricularis Endothelial cells, densely packed collagen, elastin 
Maintains valve resilience, 
allows stretch in response to 
pressure changes 
(Merryman et al., 2006a; Merryman et al., 2006; Schoen FJ; Simionescu,2006; 
Vesely,2004) 
 
In a healthy heart, the layers of the valve leaflets have stiffness levels ranging 
from 7 to 9 kPa (Liao et al., BMES. 2004).  The anisotropic and heterogeneous properties 
of the valves contribute to higher stiffness in the circumferential direction than in the 
radial direction (Billiar et al., 2000). 
Leaflets endure wide ranges of stretch under constant cyclic pressure of about 19 
kPa during diastole (Simionescu,2006).  The commissures, or attachment site of the 
leaflets to the artery wall, is known to stretch 10 to 15% of its resting size (Ranga et al., 
2004).  Stretch level increases towards the ends of each leaflet, as levels greater than 25% 
have been recorded in the aortic valve (Chong et al., 1978).  Stretching during diastole 
accounts for 60% of valve cycle (Merryman et al., 2006a).  The frequency and 
physiology of normal heart valve cycle is shown in Figure 1. 
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Figure 1:  Frequency and physiology of heart valve cycle 
Adapted from (Merryman et al., 2006a). 
 
2.1.2 Pathological Conditions 
Valvular interstitial cells (VICs) respond to changes in stiffness and stretch and 
are known to remodel valve leaflets, leading to valvular disease (Masters et al., 2004a; 
Rabkin et al., 2001).  Changes in stiffness of the tri-layered tissue is used as an indicator 
of valve damage from disease or fatigue (Merryman et al., 2006; Simionescu,2006).  
Mechanical degradation commonly leads to conditions such as stenosis, regurgitation, or 
degeneration of the valve leaflets.  The majority of diseases are irreversible, as valves do 
not have the ability to adequately regenerate damaged tissue (Simionescu,2006).  
Understanding the effect of specific mechanical stimuli on cellular response in leaflets 
can lead to improved valve replacement options and treatments.  However, the details on 
the physiological influence of VICs on remodeling and dysregulation in pathological 
states are not yet fully understood (Masters et al., 2004a; Rabkin et al., 2001). 
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2.2 Valvular Interstitial Cells and Myofibroblasts 
The pathway of mechanical stimuli on valvular interstitial cells (VICs) is through 
the extracellular matrix (ECM) that surrounds the cells to provide support and signaling.  
Cell response to these stimuli results in the synthesis and remodeling of the ECM and its 
components to sustain the structural integrity of the heart valve leaflets (Gupta et al., 
2006).  Representing about 78% of the cellular population in normal leaflets, aortic VICs 
(aVICs) are the most prevalent type of cells in the aortic valve (Merryman et al., 2006a).  
To facilitate VIC research, fibroblasts are used due to their similarities to VICs in their 
inactivated states. 
When the ECM is damaged, it is believed that the VICs differentiate into a 
contractile phenotype to aid in maintenance of the leaflet.  The new phenotype is similar 
to myofibroblasts, which play an important role in repair of most organs and tissues 
(Powell et al., 1999).  Detection of the level of alpha smooth muscle actin (aSMA) 
expressed signifies this myofibroblast presence. 
Phenotypical change is directly influenced by mechanical stresses induced from 
stretching or stiffening of tissue (Yeung et al., 2005).  Normally, when maintenance is 
completed, the myofibroblasts are eliminated via apoptosis (Gabbiani,2003; Merryman et 
al., 2006; Rabkin et al., 2001).  However, when differentiation is uncontrolled and 
apoptosis is inadequate, the increase in contractile force caused by excess myofibroblasts 
is believed to be the stimulus that causes pathological states of valve tissue (Walker et al., 
2004). 
2.3 Mechanical Stimuli Influence on VICs 
The activity and morphology of cells and tissue has been shown to be affected by 
factors such as substrate stiffness (Discher et al., 2005; Engler et al., 2004a; Gray et al., 
2003; Lo et al., 2000; Wang et al., 2000) and substrate stretch (Xing et al., 2004).  This 
section outlines devices for imposing stretch, stretchable membranes, and substrates for 
cell adhesion and stiffness adjustment considered in the final design. 
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2.3.1 Effects of Stretch 
Cultured in vitro, VICs respond to mechanical stimuli in their growth environment, 
demonstrating significant variations in cellular alignment, growth response, and cellular 
interactions (Ku et al., 2006; Neidlinger-Wilke et al., 1994).  Under cyclic loads, VICs 
have been shown to remodel the ECM through increased collagen synthesis and release 
of growth factors, with increasing response to greater strains (Ku et al., 2006).  In vivo, 
VICs are constantly exposed to cyclic mechanical loads, with varying magnitude and 
frequency correlating to pressure and heart rate, respectively (Atance et al., 2004).  This 
cyclic stretch of the aortic and mitral valve leaflets has been characterized as biaxial in 
nature (Billiar et al., 2000; Grashow,2005; May-Newman et al., 1995; Sacks et al., 2003; 
Wells et al., 2002).  Figure 2 illustrates three methods of stretch often utilized in devices: 
uniaxial, biaxial, and equibiaxial.  Uniaxial and biaxial stretch result in cellular alignment 
due to directionality within strain fields during cell culture in vitro.  Equibiaxial stretch 
applies uniform strain in all directions.  Therefore, this method of stretch can be used to 
avoid strain field directionality for simplification of analysis of the final design. 
 
Figure 2:  Methods of stretch 
2.3.2 Devices for Stretch 
A stretching device is required to study the combined effects of substrate stiffness 
and applied cyclic mechanical stretch on VICs.  Applying controlled cyclic loads requires 
programmable, precise, repeatable, durable, and easy to use equipment.  In addition to 
this core functionality, the equipment should be cost and time effective. 
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 Several methods for effectively applying cyclic equibiaxial loads to membranes 
have been used, including direct physical substrate displacement (Lee et al., 1996; 
Tschumperlin et al., 1998), positive pressurization (Winston et al., 1989), and vacuum 
over frictionless platens (Flexcell International Corp.,2003; Brown,2000).  One method 
of direct physical substrate displacement designed by Tschumperlin and Marguiles is 
shown in Figure 3.  This device has adjustable cyclic frequency and an indentor that can 
be set at different displacements into the substrate to change the stretch percentage.   This 
design accommodates one sample at a time (Tschumperlin et al., 1998).  Butcher and 
Nerem have developed a similar apparatus to apply cyclic equibiaxial stretch to multiple 
samples inside an incubator (Butcher et al., 2006). 
 
 
Figure 3:  Equibiaxial stretch device – cam driven indenter.  
Adapted from (Tschumperlin et al., 1998). 
 
The device shown in Figure 4, developed by Lee and colleagues, applies 
equibiaxial stretch to a membrane using three concentric cylinders in conjunction with a 
threaded screw top.  The automated rotation of the screw top causes the indenter ring to 
apply a load to the membrane.  This device accommodates a single sample at a time (Lee 
et al., 1996). 
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Figure 4:  Equibiaxial stretch device – screw driven indenter ring 
 
Methods of positive pressurization have also been used to stretch membranes 
equibiaxially.  One application of this method was used by F. K. Winston and his 
colleagues.  This system uses membranes clamped peripherally by o-rings.  Pressure from 
a central reservoir is regulated by solenoid valves to inflate the membrane, as shown in 
Figure 5 (Hasegawa et al., 1985; Williams et al., 1992; Winston et al., 1989). 
 
 
Figure 5:  Equibiaxial stretch device - positive pressure 
 
The Flexercell FX-4000T device, manufactured by FlexcellTM International 
Corporation (Hillsborough, NC), uses vacuum pressure to apply equibiaxial strain to a 
cultured cell environment.  The vacuum regulates the waveform and stretches the 
membrane over a nearly frictionless platen (see Figure 6), creating consistent stretching 
characteristics.  A computer software program enables the user to set up and initiate tests 
with precise control over many parameters, including cycle frequency, stretch percentage, 
duration, and deformation pattern in each run cycle.  This device is self-regulating with 
the capacity for multiple cycles that can be programmed to run in sequence.  The culture 
plates are suitable for use on a single incubator shelf, as the majority of components can 
be placed in close proximity, outside of the incubator.  This Flexercell accommodates up 
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to forty-eight samples at a time.  It is also the only commercially available equibiaxial 
stretch device that allows other researchers to easily perform the developed procedure 
(Flexcell International Corp.,2003; Brown,2000). 
 
 
Figure 6:  Equibiaxial stretch device with frictionless platen 
2.3.3 Membranes for Stretch 
 Silicone elastomere is used in the commercial Flexcell plates because of its 
flexibility and endurance to withstand cyclic stretching.  The transparency of this material 
facilitates optical imaging of cells.  However, the hydrophobic properties of silicone 
make it unusable for cell culture unless treated with cell attachment agents (Lateef et al., 
2002).  Latex is a durable highly elastic material with many uses.  As a byproduct of 
plants, it contains natural protein allergens.  These proteins leach out of the material and 
can cause hypersensitive allergic response upon exposure.  Nitrile rubber is a synthetic 
latex material that does not contain the protein allergens that exist in natural latex.  
However, nitrile rubber is not as elastic as latex or silicone. 
2.3.4 Effects of Stiffness 
 Rigid substrates affect cell morphology and activity differently than soft 
substrates when they are seeded at low densities to prevent cellular interactions.  For 
instance, when fibroblast cells are cultured on substrates containing a gradient of rigidity 
(140-300 kdyn/cm2), the cells preferentially migrate toward the stiffer side of the 
substrate (Lo et al., 2000) and accumulate (Gray et al., 2003).  Fibroblasts also generate 
significantly stronger traction forces on substrates of higher stiffness (Lo et al., 2000).  
Aortic smooth muscle cells grown on soft gels (E~1 kPa) are rounded while cells grown 
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on stiffer gels (E~60 kPa) and glass are dendritic and flat which increases organization of 
their focal adhesions and cytoskeleton (Engler et al., 2004a). 
 Cells in the aortic heart valve respond to changes in valve stiffness resulting from 
calcification or structural degradation.  Cell differentiation into myofibroblasts has been 
displayed by comparing cells on compliant leaflets, where relatively few myofibroblasts 
are seen (Della Rocca et al., 2000; Schenke-Layland et al., 2004).  Studying cells on rigid 
plastic has shown that up to 60% differentiate into myofibroblasts, as evidenced by 
increased aSMA expression (Bertipaglia et al., 2003). 
2.3.5 Substrates for Stiffness 
There are many substrates available for altering stiffness and adhering cells.  The 
substrate must be biocompatible while accepting and promoting cell growth and 
attachment without being remodeled by the cells.  It must also have an adjustable 
stiffness (over a range of 7 to 75 kPa), with consistent surface properties at each level of 
stiffness.  The ability to be stretched repeatedly, without tearing or deformation, is also 
required.  The substrates under consideration are discussed in this section. 
 
Polyacrylamide 
Polyacrylamide (PA) is a hydrophilic crosslinked copolymer with highly 
adjustable stiffness.  This hydrogel is often used for determining effects of stiffness on 
cell growth and morphology (Semler et al., 2005).  Polymerization begins with the 
addition of an initiator to the solution, connecting monomers to form polymer chains.  
Stiffness levels can be altered by changing the ratio of acrylamide to bis-acrylamide or 
the amount of the initiator prior to polymerization.  To create a more compliant and 
stretchable copolymer, these factors are adjusted to decrease the amount of crosslinking 
and chain length.  However, cellular attachment to polyacrylamide requires the 
incorporation of an adhesive material such as collagen or fibronectin. 
 
Polydimethylsiloxane  
Polydimethylsiloxane, (PDMS) is a non-reconstructable, inexpensive, and 
hydrophobic silicone widely used in research.  The stiffness of PDMS is adjusted by 
altering concentrations of the crosslinking agent and monomer base which, when 
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combined, begin the curing process.  Unfortunately, surface properties have been shown 
to change dramatically over varying levels of stiffness.  Low stiffness levels of PDMS 
have been characterized as toxic to cells.  This is believed to be due to the excess 
presence of uncrosslinked monomers (Brown et al., 2005). 
 
Polyethylene-glycol 
Polyethylene-glycol (PEG) hydrogels have been extensively used in tissue 
engineering applications as scaffolds due to their biocompatibility, hydrophilic 
properties, and resistance to protein absorption (Hahn et al., 2006b; Hahn et al., 2006c; 
Underhill et al., 2007).  PEG hydrogels are highly elastic, allowing them to be used in 
vascular research as they can withstand extended periods of mechanical stress (Hahn et 
al., 2006a).  The initiators used in the polymerization of PEG can be activated through 
UV or white light exposure.  Gel stiffness is customized using different molecular 
weights of PEG or altering chain length through the addition of degradable linkages or 
adhesive peptides (Underhill et al., 2007).  Incorporation of a peptide, such as arginine-
glycine-aspartic acid-serine (RGDS), into diacrylated PEG is needed to create sites for 
cellular adhesion (Hahn et al., 2006b; Hahn et al., 2006c). 
2.3.6 Combined Effects of Stretch and Stiffness 
Although much research has been done on the effects of substrate stiffness and 
stretch on cellular environments, a current method does not exist to study their combined 
effects.  Simultaneously applying controlled stiffness and stretch to the cellular 
environment would more realistically model growth conditions found in vivo.  This 
method would facilitate improved research techniques leading to a clearer understanding 
of normal and pathological heart valves for improved treatment options and biologically 
active replacements. 
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Chapter 3:  Project Approach 
This chapter discusses the identification, approach, and development of a method 
to equibiaxially stretch valvular interstitial cells (VICs) on substrates of different levels of 
stiffness.  All assumptions made in the approach and methods for developing the final 
project statement and for reference at the conclusion of the project are identified.  
Specific aims and tasks are discussed to outline the detailed guidelines and boundaries 
used to determine what the overall project ultimately accomplished – a method to 
simultaneously apply controlled levels of stretch and stiffness to cell culture substrates. 
3.1 Assumptions 
The project statement was simplified using various assumptions for the purpose of 
developing our method.  It was assumed that the cells attached to the substrate are 
subjected to the same stretch percentage and strain patterns as the substrate.  The 
substrate was also assumed to be a flat, isotropic, and homogenous material to simplify 
analysis relative to changes in stretch and stiffness.  Triangular arrangements of dots and 
graphite particles were used as markers for strain measurement of the membrane or 
substrate, respectively.  It was assumed that each arrangement could be described by a 
system of equations relating deformed and non-deformed configurations by position. 
3.2 Specific Aims and Tasks 
Completion of specific tasks was required to develop a method to apply controlled 
levels of equibiaxial cyclic stretch and stiffness to a cellular environment.  Tasks 
included: 
1. Selecting a stretch device 
2. Choosing an fatigue resistant and elastic membrane that allows substrate 
attachment 
3. Determining the proper substrate with adjustable stiffness 
4. A cell attachment procedure for cell adhesion to the substrate 
The combination of each of these aims and tasks allowed the cellular environment to be 
subjected to controlled levels of stretch and stiffness. 
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Chapter 4:  Design 
A complete method was developed to equibiaxially stretch cells on substrates of 
different levels of stiffness.  The design process presented in this section was followed 
throughout research and can be found in Dym and Little’s (2004) design book 
“Engineering Design:  A Project-Based Introduction”. 
 Preliminary interviews, review of a previously completed Major Qualifying 
Project entitled “A Method for Determining the Effect of Stiffness and Stretch on Cell 
Phenotype” (2006), and other research provided background information and 
experimental protocols.  A comprehensive design attributes list was compiled and divided 
into important objectives, functions, and constraints.  Analysis was completed to 
prioritize the objectives in the project method (see Appendix C).  Decision matrices were 
used to evaluate and select the best materials and methods for our design.  These 
guidelines aided in the development of design alternatives and selection of the final 
design.  In subsequent sections of this chapter, preliminary tests and the chosen method 
are discussed. 
4.1 Design Goals and Specifications 
It was necessary to clarify our project goals, constraints, and functions in order to 
improve and expand the initial project statement: to design and validate a method to 
apply combinations of different levels of stiffness and stretch to cell culture substrates.  
To identify project goals, the pruned objectives, functions, and constraints lists were 
specified for both the substrate as well as the stretching device. 
The weighted objectives tree for the overall method is illustrated in Figure 7 and 
Figure 8.  Adaptability (different cell types and assays), user friendliness (simplicity and 
ease of use), durability (component wear and replacement), expense, and time efficiency 
were compared in relation to each other.  The importance of each was determined 
through the use of pair-wise comparison charts. 
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Figure 7:  Weighted objectives trees 
 
Effectiveness was evaluated separately from the other top-level objectives, as it was 
determined to be completely vital to the success of the design.  As shown in Figure 8, the 
sub-objectives of effectiveness were assessed and weighted.  Cell viability was 
considered the most important objective in comparison to repeatability, stretch and 
stiffness ranges, cell adhesion, and assay compatibility. 
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Figure 8:  Weighted effectiveness sub-objectives tree 
 
4.1.1 Objectives, Functions, and Constraints 
 Specific project objectives were determined for the substrate and the stretching 
device to better define the goals, performance, and limitations for each part of the 
method.  The objectives, functions, and constraints for the substrate, membrane, and 
stretching device are shown in Table 2, Table 3, and Table 4. These tables show the 
deciding factors of our rationale used in the design process. 
 
Table 2:  Objectives for stretching device, membrane and substrate 
Objectives 
Stretching Device Membrane for Stretch Substrate for Stiffness 
• Stretch membrane cyclically 
for at least 2 days 
• Easy to use 
• Relatively inexpensive 
• Time effective 
• Fit in an incubator 
• Relatively inexpensive 
• Easy to use 
• Elastically stretchable 
• Isotropic properties 
• Substrate compatible 
• Biocompatible 
• Adjustable stiffness ( 7-75 
kPa ) 
• Homogeneous surface 
properties 
• Relatively inexpensive 
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Table 3:  Functions for stretching device, membrane and substrate 
Functions 
Stretching Device Membrane for Stretch Substrate for Stiffness 
• Stretch membrane 2-20% 
• Stretch cyclically at 1.0 Hz 
• Stretch equibiaxially 
• Withstand 2-20% stretch 
• Resist fatigue (>2 days at 
1.0 Hz) 
• Promote adhesion strong 
enough to endure stretch 
• Stretch cyclically up to 
20% for at least 2 days 
• Comply with image 
analysis 
• Promote cell viability (75%)
 
Table 4:  Constraints for stretching device, membrane and substrate 
Constraints 
Stretching Device Membrane for Stretch Substrate for Stiffness 
• Cost < ~$2000 
• Fit inside incubator 
• < 3 hour set up 
• Cell attachment 
• Stretch 2-20% 
• Run for 2 days 
• Multiple samples 
• User Independent 
• Limited impact on cells 
• Substrate compatible 
• Elastically stretchable 
• Isotropic properties 
• Bio-compatible 
• Stiffness 
• Stretchable 
• Not remodeled by cells 
 
4.1.2 Problem Statement 
 Based upon the above analysis, our final project statement was expanded:  
Design and validate a method to apply controlled levels of stretch and stiffness to cell 
culture environments for future studies of the effects of these stimuli on the phenotype of 
valvular interstitial cells.  The method should allow stretching from 0 to 20% as well as 
stiffness levels ranging from 7 to 75 kPa to simulate conditions experienced by the heart 
in vivo. 
This statement includes the most important design goals considered in formulating 
and constructing the final method design.  To achieve the above objectives, testing and 
validation of other designs for feasibility and efficacy was performed prior to determining 
the final method. 
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4.2 Method Development and Design Alternatives 
Extensive research, preliminary designs, and testing were required to arrive at the 
final method.  The following primary design components and their requirements were 
identified: 
• Stretch device for cyclic equibiaxial stretch of the membrane 
• Substrate with adjustable stiffness  
• Elastic and fatigue resistant membrane that allows substrate attachment 
• Method for cell adhesion to the biocompatible substrate 
Decision matrices and testing performed throughout the design process allowed 
assessment of possible design components for the final method.  This section discusses 
the rationale behind choosing the stretching device.  Then, each alternative design 
involving the membrane, substrate, and cell adhesion method are discussed in sequence 
with respective testing.  This allowed either elimination based on testing failure, or 
application for use in the final developed method. 
4.2.1 Stretching Device 
Several devices and methods for applying cyclic equibiaxial stretch to substrate 
membranes were compared.  Tschumperlin’s or Butcher’s cam driven method is simple 
in construction and design.  However, the stretch pattern is not easily adjustable, as it is 
limited to the shape of the cam.  While Butcher’s device fits inside of a standard 
incubator and allows for multiple samples, Tschumperlin’s does not (Butcher et al., 2006; 
Tschumperlin et al., 1998).  Lee’s screw indentation method is inexpensive and has the 
ability to apply desired levels of stretch, but is limited to a single sample and is not 
variably programmable (Lee et al., 1996).  Winston’s positive pressurization device is not 
suitable for use inside an incubator because the deflection measurement devices are 
sensitive to moisture and require accessibility.  In addition, the strain patterns have 
inconsistent characteristics, which exacerbate over time as the membrane is inflated 
repeatedly (Hasegawa et al., 1985; Williams et al., 1992; Winston et al., 1989).  
Flexercell FX-4000T will not allow high stretch percentages at frequencies above 1.0 
Hertz (Hz).  Additionally, silicone is the only membrane available in the Flexcell culture 
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plates (Flexcell International Corp.,2003; Brown,2000).  However, Flexercell does meet 
our requirements for user independence, time efficiency, ease of use, and ability to 
accommodate multiple samples within the incubator. 
Using the decision matrices shown in Appendix D, it was determined that the 
Flexercell was the only qualified device based on our constraints.  The designs of 
Tschumperlin, Lee, and Winston were eliminated due to their incompatibility with the 
constraint of fitting inside the incubator.  Butcher’s device was eliminated due to high 
start up costs.  Though Flexercell cost does not meet our constraint, our group has access 
to the device.  Another benefit of the Flexercell is that it is the only commercially 
available device, allowing easy replication and validation of the results achieved in this 
study (Flexcell International Corp.,2003; Brown,2000). 
4.2.2 Polymer Substrates for Adjusting Stiffness 
Based upon our decision of using the Flexercell FX 4000T stretch device, it was 
necessary to choose a compatible substrate that fulfilled our objectives.  For proper 
mechanics and stretching with the Flexcell plates, the substrate had to be either 
chemically or physically bonded to the silicone membrane.  It also had to be able to reach 
stiffness levels from 7 to 75 kPa as well as withstand cyclic stretch up to 20% at each 
stiffness level for at least 2 days.  The surface properties of the polymer substrate had to 
be homogeneous and flat to avoid inconsistent cellular activity.  Biocompatibility and 
resistance to remodeling by the cells were necessary features critical to data analysis. 
 As shown in the substrate decision matrix in Table 5, the only non-eliminated 
substrate materials after initial research included polydimethylsiloxane (PDMS), 
polyacrylamide (PA), and polyethylene-glycol (PEG). 
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Table 5:  Substrate decision matrix 
 Bio-compatible Not Remodeled by Cells Stiffness Stretchable 
PDMS Yes Yes Yes Yes 
PA Yes Yes Yes 9, 10, 11, 22 Yes 
AGAROSE Yes   No7 
HEMA    No16 
Alginate Yes No4   
PEO   No15  
PEG Yes17,18  Yes19,20 Yes21 
HA Yes No5   
Collagen Yes No5   
PU  No16 No 13,14  
PLA    No6 
PGA    No12 
PVA    No3 
Fibrin Yes No1   
Gelatin Yes No2   
Chitosan Yes No8   
See Appendix D for decision matrix reference key 
 
Polydimethylsiloxane  
 PDMS substrates are relatively inexpensive to make and can be polymerized 
directly onto the Flexcell silicone membrane.  We hypothesized however, based on 
literature, that the 80:1 PDMS base-to-crosslinker ratio needed to achieve a stiffness of 
about 75 kPa is toxic to cells because of the excessive number of uncrosslinked 
monomers (Brown et al., 2005; Shivkumar,2006).  Therefore, if this material was to be 
used in our design, we concluded that it must be restricted for use as an intermediate 
material in the form of posts at the manufacturer’s recommended mixing ratio of 10:1.  
Examples of these posts are described section 4.2.4. 
 
Polyethylene-glycol 
 PEG hydrogels are polymerized by mixing the correct amounts of monomers in 
HEPES buffered saline (HBS), then adding either a white or an ultraviolet light initiator 
to begin the formation of the polymer and thus, the hydrogel.  When preparing for the 
attachment of cells, PEG diacrylate (PEGDA) must be used with RGD cell adhesion 
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peptide.  This is a more complicated and delicate procedure than preparing PEG, 
requiring equipment not immediately available to our project group. 
 Initial tests with PEG were made possible through the donation of 10,000-
molecular-weight PEGDA powder with incorporated RGD by another lab for the 
preparation of the 10% PEGDA gel solution.  This completed the first two parts of the 
PEG protocol in Appendix G and circumvented the problem of inadequate equipment.  
The pilot experiments performed with PEG were completed to determine if it could be 
polymerized onto and form a chemical bond with the Flexcell silicone membrane.  These 
tests revealed that PEGDA would polymerize on top of glass and silicone, but a thin layer 
of unpolymerized PEGDA prevented the covalent attachment of PEGDA to the surface. 
 As a possible solution, both circular and sectioned hydrophilic rings of porous 
polyethylene (PPE) were glued to the silicone membrane using MED3100FC medical 
grade silicone adhesive (Dow Corning).  These rings are described in section 4.2.3.  This 
would create a physical means of attachment for the PEG.  In these tests, the PEG 
diffused into the PPE and formed a strong bond once polymerized.  When using the 
sectioned rings, high stress concentrations occurred at each division, causing the gel to 
tear.  It was determined that PEG hydrogels could be used as a substrate if attached to the 
Flexcell silicone using circular PPE rings. 
 
Polyacrylamide 
 The process of polymerizing PA hydrogels between two glass coverslips is a 
copolymerization of acrylamide and bis-acrylamide (“bis,” N,N’-methylene-bis-
acrylamide).  It involves mixing specific amounts of acrylamide, bis, water, and buffer to 
create the desired gel stiffness.  Ammonium persulfate (APS) and 
tetramethylethylenediamine (TEMED) are then added to the solution to initiate the vinyl 
addition polymerization process by generating free radicals (Menter). Free radicals are 
highly reactive molecules with unpaired electrons and are therefore likely to take part in 
chemical reactions. 
4.2.3 Initial Substrate Tests 
Initial testing and research allowed assessment of possible options for using 
PDMS, PEG, or PA in our final method design.  PDMS was eliminated because the 
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uncrosslinked monomers present in low stiffness levels needed for our project cause the 
material to be toxic to cells.  We were unable to modify both PEG and PA to covalently 
bond to the silicone membrane of the Flexcell Device.  Therefore, we looked into 
physical means of attachment. 
4.2.4 Physical Substrate Attachment Designs 
Alternative designs involving an additional intermediate material were considered 
for attachment to the Flexcell silicone membrane to circumvent each substrate’s inability 
to chemically bond.  Along with PEGDA, PA was also found to absorb into hydrophilic 
PPE sheeting and polymerize to create a physical bond.  Other alternatives for physical 
attachment include the use of glass beads or stiff silicone posts and using the naturally 
sticky 80:1 PDMS to glue dried PA to the membrane, followed by rehydration.  Many 
preliminary designs were also developed to facilitate application of the silicone or PPE 
intermediary material.  Although these physical attachment designs were not used in the 
final method, each concept was used in our design process. 
 
Porous Polyethylene Rings 
Porous polyethylene can be cut into a ring for a means of physical attachment of 
both PA and PEG to silicone.  PPE was found to successfully adhere to the Flexcell 
silicone membrane using a MED3100FC medical grade silicone adhesive.  Additional 
analysis, testing, and variations in design were required to achieve the best possible 
stretch characteristics. 
 The size and placement of this ring has direct influence on stretch characteristics 
as well as the internal forces created in the substrate.  The two designs for placement of 
the ring are illustrated in Figure 9 and Figure 10.  In both figures, red indicates the 
intermediary material, blue indicates the platen, and orange indicates the substrate.  
Figure 9 represents a PPE ring concentric to the Flexcell plate well, with its outer 
diameter slightly smaller than the well diameter.  Its inner diameter is small enough to fit 
around the platen when pulled down from the vacuum force during stretching.  
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Figure 9:  Intermediary material ring adhered to membrane at outer edge 
 
Sectioned Porous Polyethylene Rings 
Figure 10 is a sectioned ring sized to fit concentrically within the area of the 
platen, even during maximum theoretical stretch of 20%.  This ensures that the material 
would only be stretched over the surface of the platen, in contrast to the previous design.  
As porous polyethylene is a rigid material, sectioning of the ring would be required 
during equibiaxial stretch to prevent undesired cracking of the ring or separation from the 
membrane.  However, the use of a sectioned ring introduces high levels of stress 
concentrations in the substrate, which are hypothesized to cause tearing.  Both methods 
were considered as possible applications of intermediary materials. 
 
 
Figure 10:  Intermediary material ring adhered to membrane over platen 
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Glass Beads 
 Small glass beads were embedded into the top layer of PDMS as shown in Figure 
11.  This created a glass “surface” that would be free to stretch equibiaxially.  After 
chemical activation of the surface, the beads were hypothesized to allow covalent 
attachment of PA to the membrane.  However, preliminary testing using this idea resulted 
in the PA not being able to polymerize on the surface. 
 
Figure 11:  Glass beads in PDMS 
 
Re-hydration of PA on 80:1 PDMS 
 PA was dried and re-hydrated with 1X PBS to near its original shape.  Since the 
80:1 ratio of PDMS is very sticky, it was hypothesized that the PA would stick to that as 
it dried, then could be re-hydrated and stay attached to the PDMS.  However, testing this 
design idea resulted in no sticking of the PA to the PDMS. 
 
Vertical Posts 
High-density PDMS posts can be cast and bonded to the silicone membrane in a 
circular pattern.  This silicone can be easily made in the form of SylGard 184 at a high 
stiffness using a 10:1 ratio of PDMS to cross-linker.  The substrate solution would be cast 
on a platform with abutments to form pre-made holes in the same circular arrangement as 
the posts on bonded to the membrane (see Figure 12). 
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Figure 12:  Post placement over platen (top view) 
 
This polymerized substrate would be transferred to the membrane and secured to the 
posts.  The shape of each post would need to mechanically hold the substrate to the 
membrane to prevent slippage during stretching.  This could be achieved by creating 
posts angled outward from the center of the well, or by creating posts with a larger top 
cross sectional area.  Both design options create challenges that require testing to evaluate 
their feasibility for use.  Important points include ease and reliability of substrate 
attachment to the post material.  Figure 13 shows rigid silicone posts angled outward 
from the center of the well with an attached membrane, which would be pre-cast with 
corresponding holes.  Figure 14 represents rigid silicone posts with a larger cross 
sectional area on the top end with an attached membrane, also pre-cast with holes.  
Limitations to these designs may include high stress concentrations around each post that 
could tear the gels. 
 
 
 
Figure 13:  Posts attached to membrane - angled outward (side view) 
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Figure 14:  Posts attached to membrane - larger top (side view) 
 
Attempts to polymerize both PA and PEG using physical attachment means were 
found to result in tearing of the gels.  Therefore, we looked into chemical means of 
attachment of the substrates to the silicone membrane of the Flexcell culture plates. 
4.2.5 Chemical Substrate Attachment 
Since we were unable to modify PEG to attach to the silicone membrane of the 
Flexcell device, we decided to focus our research on using PA because of its extensive 
use in cell studies.  In addition, Yu Li Wang at UMASS Medical School has a protocol 
(Appendix F) that allows PA to be polymerized on glass.  Our first attempt therefore, was 
to modify this method and figure out how to get PA to polymerize and attach to the 
silicone membrane.  The method used to polymerize PA is shown in Figure 15. 
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Figure 15:  Polyacrylamide gel polymerization 
1) TEMED acts as a catalyst by accelerating the rate of formation of free radicals 
from persulfate.  2) Ammonium persulfate splits to form two free radicals (a).  3) 
Persulfate free radicals attach to and convert acrylamide monomers to free radicals 
(b).  4) Acrylamide free radicals react with inactivated monomers to begin the 
polymerization chain reaction.  5) Inactivated bis monomers randomly crosslink the 
acrylamide chains via the same free radical chain reaction to create the crosslinked 
copolymer (c).  (Menter) 
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 Problems arose when attempting to polymerize PA hydrogels on a surface other 
than glass, such as the silicone membrane available in the plates provided by the Flexcell 
company.  These tests were done both with and without glass coverslips on top of the PA.  
Some tests were completed to create a gel more than 2 mm thick.  When thick gels were 
tested, the bottom half did not polymerize, while the top half (in contact with glass) did 
polymerize.  Both glass and silicone have inert surfaces, which minimally interact with 
other materials.  However, silicone contains more variable elements than the simple 
silicon dioxide configuration of glass.  For this reason, it was theorized that something in 
the silicone was inhibiting the polymerization of PA.  Different methods of 
polymerization were investigated to use PA as the substrate with the stretching device. 
 First, alternate surfaces for polymerization were tested.  These materials are listed 
in Table 6.  When the PA did not polymerize on any of these surfaces, silanization (see 
Appendix L) of the surface prior to polymerization was attempted.  Silanization is a 
process used to chemically activate a surface for the covalent attachment of a polymer.  
The mechanism for silanizing glass is shown in Figure 16.  This method is known to 
facilitate the adherence of PA to glass.  After failure of this attempt on all surfaces, 
further investigation into the reaction was performed. 
 
Table 6:  Materials used in testing PA polymerization 
 Surfaces for 
Polymerization 
Modifications for 
Attachment  
 
PDMS (10:1) 
PDMS (80:1) 
Latex 
Silicone Glue 
Weigh Dishes 
Parafilm 
Saran wrap 
Plexiglass 
Teflon 
 
 
 Thicker layer of PA gel  
Silanization 
 
 
 
Riboflavin 
Dry and rehydrate 
Glass Beads 
AIBN 
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Figure 16:  Silanization of glass with plasma oxidation or NaOH 
1) Drying NaOH on the surface or plasma oxidation attaches hydroxyl groups to the 
surface.  2)  Attachment of 3-Aminopropyltrimethoxysilane (3-Amino) to the 
hydroxyl groups to supply primary amine groups.  3) Attachment of 
Glutaraldehyde to amine group of 3-Amino to form an imine group, thus supplying 
an aldehyde group.  The amine group of the acrylamide will later covalently bond 
with this aldehyde group to form another imine and thus, covalently attach 
polyacrylamide to glass. 
 
 It was found that oxygen in the atmosphere and in the solution inhibit 
polymerization.  Oxygen in the atmosphere usually exists in its triplet state, shown in 
Figure 17.  This means that the oxygen molecule, O2, is actually two free radicals 
combined.  Thus, when oxygen encounters another free radical molecule, it readily reacts 
with that molecule to stabilize itself and the other molecule.  Riboflavin-5’-phosphate 
(riboflavin) is another common initiator for PA.  It uses oxygen and light to begin free 
radical formation and polymerization. 
 
Figure 17:  Triplet oxygen 
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 In hopes that oxygen was the only factor inhibiting polymerization, a combination 
of riboflavin, APS, and TEMED were tested as initiators on most of the surfaces, 
silanized and non-silanized.  When tested under glass coverslips, many of the tests 
resulted in polymerization of only the PA on the outer ring of the gel, which was in 
contact with the atmosphere.  When tested as drops on the surface, the top of the drop 
polymerized while the bottom did not polymerize.  These tests revealed that the 
polymerization problem was independent of oxygen.  It was theorized that the problem 
was the result of an unknown interaction between the acrylamide monomers and the 
surface of all materials tested other than glass. 
Other types of initiators were then sought for the purpose of finding something 
that would cause PA to polymerize on the Flexcell silicone membrane.  A UV initiator, 
azobisisobutyronitrile (AIBN), was tested on the flexcell membrane, as it has been shown 
to fully polymerize when in contact with PDMS (Zaari et al., 2004).  Initial tests resulted 
in nearly complete hydrogel polymerization with a very thin layer of unpolymerized PA 
between the gel and the silicone surface.  Though it was not attached, the PA 
polymerized in the presence of a surface other than glass.  Further tests involving 
silanization (Appendix L) of the surfaces revealed that when using AIBN initiator, PA 
polymerizes and forms a weak covalent bond to latex and nitrile.  A substrate and 
membrane combination had been discovered that allowed covalent attachment.  To 
increase the strength of the covalent bond, plasma oxidation (Appendix K) was used to 
attach hydroxyl groups to the surface of the latex.  This in turn made the latex more 
hydrophilic and thus improved silanization or activation of the latex.  The PA substrate 
could then form a very strong covalent bond with the latex membrane. 
4.2.6 Elastic Membranes for Applying Stretch 
Based on preliminary testing results with PA, the only feasible membranes for 
stretch considered in our final design were latex and nitrile because of the covalent 
attachment of PA to their surface.  Ideal conditions would have permitted the use of the 
Flexcell silicone because it is already part of the Flexcell plates.  However, since the 
chemical attachment of a substrate for our specific method was never successfully 
completed, the use of the different membrane to achieve the same goal was required.  
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Using plasma oxidation with AIBN initiator to successfully polymerize polyacrylamide 
onto both latex and nitrile was a paramount discovery. 
The elasticity of latex is preferable for withstanding vacuum pressure, resisting 
fatigue, and achieving high strain as compared to nitrile.  Therefore, latex was chosen for 
the stretch membrane.  The design process continued with the assessment of proper 
thickness of ideal latex that would be thick enough to create a seal, but thin enough to 
allow stretching up to 20%.  Leaching the latex in water prior to plate assembly was 
performed to eliminate the potential for proteins to leach into polyacrylamide and cell 
media, which could have adverse effects on the cells. 
4.2.7 Custom Plate Design 
In order to use the latex membrane for stretch instead of the Flexcell silicone, a 
modified BioFlex culture plate was necessary.  The BioFlex plate, shown in Figure 18, 
was separated into the upper and bottom pieces to remove the silicone membrane, and 
then fitted together to drill holes at the appropriate locations.  A pre-stretched sheet of 
latex was placed between the pieces, and the plate was reassembled using bolts, nuts, and 
sealing washers. 
 
 
Figure 18:  BioFlex culture plate 
 
 In order to create uniform strain in each well, a pre-stretch method was essential 
to apply strain to the membrane prior to assembly.  Therefore, a pre-stretch device was 
designed.  Circular sewing rings were used to prepare the membrane for equibiaxial pre-
stretch shown in blue (Figure 19a).  A circular wooden holding base was designed to 
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secure the inset bottom piece of the pre-drilled plate.  The sewing rings were then placed 
over the holding base to allow equibiaxial pre-stretch (Figure 19b).  The final design after 
many modifications, is shown in Figure 20. 
 
 
(a) 
 
(b) 
 
Figure 19:  Pre-stretch device function 
(a) Cross section of sewing rings with latex membrane (b) Cross section of latex on pre-stretch device 
 
 
 
Figure 20:  Designed pre-stretch device 
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  It was essential to ensure that the plate was properly sealed so that it would 
withstand the vacuum pressure applied by the Flexcell diaphragm.  While thin latex can 
allow stretch levels higher than 20%, a thickness similar to that of the original silicone 
was theorized to create the best seal.  This latex was also thought to create a more 
uniform stretch than thinner latex because if its increased resilience. 
Bolt placement also modeled the original Flexcell silicone plate.  Bolts were 
placed around the plate at the same sites where the two pieces were heat-sealed originally 
(see Figure 21).  Metal and rubber washers were then used to seal any small gaps 
between the holes and the bolts. 
 
 
Figure 21:  Bolt placement on custom plate 
 
 Initial testing was done using 0.01-inch latex from Greene Rubber Company.  
Size 8 bolts were used around the perimeter of the plate, while size ¼-inch bolts were 
used in the middle.  Rubber and metal washers used under the head of each bolt were 
hypothesized to eliminate any leaks through the plate.  When putting the plate on the 
Flexcell diaphragm, usually two center Delran posts on the platen plate immobilize 
horizontal shifting during vacuum pressure (Figure 22).  For our design using nuts and 
bolts, these Delran posts had to be removed because they interfered with the two middle 
nuts. 
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Center Delran Post  
Center Delran Post  
Figure 22:  Delran posts of Flexercell design 
 
After placing the plate onto the Flexcell diaphragm, we found that there was a 
significant leak in the plate when vacuum pressure was applied.  The application of 
silicone lubricant on top of each bolt confirmed our theory that there was not a complete 
seal around the bolts.  The removal of the two Delran posts also revealed an additional 
issue in that the plate shifted so that the platens were no longer centered in the wells. 
 New stainless steel bolts, washers, and nuts were purchased in attempt to 
eliminate the plate leak and improve its placement on the Flexcell diaphragm.  The 
stainless steel materials were purchased for their corrosion resistance to eliminate 
possible contamination of the cell culture plates.  They can also be autoclaved after each 
experiment and reused in a new plate.  Size #6 and ¼-inch bolts were purchased from 
Fastenal Co. along with stainless steel bonded sealing washers.  The rationale for longer 
middle bolts was to use them for plate immobilization and centering.  The additional 
length extended down to the platen plate through the same ¼ inch holes where the Delran 
posts originally were located, as shown in Figure 23. 
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Figure 23:  Custom plate design using bolts for immobilization 
 
Different latex sheeting with a thickness of 0.014 inches was also purchased from Small 
Parts Inc., to help improve the seal between the two plate pieces.  Since the latex creates a 
natural gasket around the wells, we hypothesized that a thickness similar to that of the 
Flexcell silicone (0.020 inches) would be ideal for preventing leaks.  The new plate 
design proved to be leak free and centered when used with the Flexcell diaphragm. 
4.2.8 Cell Adhesion Possibilities 
A flat biocompatible substrate surface is necessary for proper cell attachment.  
Since stiffness properties and toxicity of PA using AIBN are not well documented, we 
decided to add an additional secondary layer onto our PA with AIBN substrate.  This top 
layer was made of PA with TEMED and APS, because the cell interaction characteristics 
are well known.  The bottom substrate layer was designed to be kept at a constant 
stiffness.  Since PA with APS has known stiffness levels and cell interactions, the second 
layer was designed to be used for stiffness adjustment. 
Before choosing a cell adhesion material, the methodology for cell testing was 
planned.  Since fibroblasts are similar in phenotype to VICs in their inactivated state, they 
were also used to validate the designed method.  Benefits of this technique compared to 
just using VICs include the facilitation of cell preparation and lower cost.  
Cell attachment to polyacrylamide requires an attachment protein.  The passive 
absorption of collagen or fibronectin onto the surface of the secondary PA substrate was 
 35
considered.  Preliminary tests revealed that neither attachment protein absorbed readily to 
the PA surface.  However, fibronectin was ultimately chosen because a method was 
found that allowed it to be crosslinked into the PA chains (see Appendix O). 
4.3 Final Designed Method 
The complete final project method was chosen based upon research, analysis, and 
preliminary testing.  The main layers used in our method are shown below in Figure 24.  
The complete design is comprised of the following components: 
• Flexercell 4000T device to equibiaxially stretch the membrane 
• Custom plate for Flexcell device and cell culture 
• Pre-stretch device for plate assembly 
• Latex membrane for stretch (0-20%) 
• Primary polyacrylamide layer with AIBN for covalent attachment 
• Secondary polyacrylamide layer with APS for tunable stiffness (7-75 kPa) 
• Fibronectin for cell adhesion 
 
Figure 24:  Substrate design 
 
The combination of these design choices was validated by culturing cells for 2 days 
inside of an incubator.  A stretch frequency of 1.0 Hz was applied to simulate normal 
heart beat cycle.  Cultured cells were attached to a thin layer of polyacrylamide 
covalently bonded to the primary layer of polyacrylamide, creating a smooth cell 
interaction layer.  The stiffness of the top layer was adjusted to levels ranging from 7 to 
75 kPa. 
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Chapter 5:  Methods 
In this section, materials and methods used to conduct and validate our 
experiments are described.  The protocols for each procedure can be found in the 
appendices. 
5.1 Construction of Six-Well Plates 
 Custom plates with a stretchable membrane that facilitated covalent attachment of 
polyacrylamide (PA) were designed and built.  First, BioFlex® Culture Plates (Flexcell™ 
International, Hillsborough, NC) were separated and cleaned.  This was done using a 
wedge and hammer to carefully separate each heat sealed section between the wells.  The 
excess heat-sealed material was then removed and smoothed using a Dremel high-speed 
rotary tool.  The four vertical corners of the plate were also removed to allow placement 
of bolts, nuts, and washers.  The two middle holes (1/4-inch) were drilled with careful 
alignment to create a centered plate.  The ten outside holes (9/64-inch) were drilled to 
allow the placement of the bolts.  After mechanical alteration, the entire plate was washed 
and rinsed.  This protocol is located in Appendix J. 
 A pre-stretched 0.014 inch thick sheet of latex (Small Parts, Inc.) was placed 
between the top and bottom portions of the separated plate.  The pre-stretching method is 
described in Appendix J.  Holes were punched in the latex with 2mm biopsy punches 
(Premier Products, Co.) and the top and bottom of the plate, with the latex between, was 
bolted together.  All hardware used in the plates was purchased from Fastenal Company.  
Stainless Phillips truss head machine screws with dimensions 1/4-20 x 3/4” were used for 
the middle two holes and #6-32 x 3/8” stainless Phillips truss head machine screws were 
used for the 10 outer holes.  Stainless steel bonded sealing washers and stainless steel 
machine screw hex nuts were used with all machine screws.  All machine screws were 
inserted from the top of the plate with a sealing washer between the head and the plate.  
Each plate was checked for pressure leaks with tubing as a localized listening device 
while under high stretch from the Flexcell device.  Any leaks detected were resolved by 
further tightening of all machine screws. 
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5.2 Chemical Activation of Latex Membrane 
 Latex was chemically modified to create binding sites that facilitate the covalent 
attachment of PA to the latex.  A glass microscope slide was used as a control.  Latex-
membrane plates were subjected to plasma-oxidation (see Appendix K) for 30 seconds in 
the Plasma Prep II device (SPI supplies).  Two milliliters of 3-aminopropyltrimethoxy 
silane (Acros Organics) was immediately placed in each well for five minutes (see 
Appendix L).  The plates were rinsed for thirty minutes in de-ionized water on a shaker 
plate with at least four replacements of the de-ionized water.  After the water was 
removed from the wells, two milliliters of 0.5% glutaraldehyde (Electron Microscopy 
Systems) was added to each well.  After thirty minutes, excess glutaraldehyde was 
removed and placed in hazardous waste trash.  The plates were rinsed for thirty minutes 
in de-ionized water on a shaker plate with at least four replacements of the de-ionized 
water.  The plates were then emptied and allowed to air dry. 
5.3 Preparation of Polyacrylamide Substrates 
Primary Layer for Covalent Attachment 
One-millimeter-thick PA substrates were prepared (see Appendix N) and 
covalently attached to each latex-bottom well in the manufactured six-well plates 
described in section 5.1.  First, 22 mm ID o-rings (Small Parts, Inc.) were attached to the 
central region of each well using MED3100FC medical grade silicone adhesive (Dow 
Corning) as described in Appendix M.  A volume of 0.5 milliliters of PA (5% acrylamide 
to 0.12% bis) was then placed inside of each o-ring in each well.  The UV-photoinitiator, 
2,2′-azobis(2-methylpropionamidine) dihydrochloride (AIBN), was used as an initiator at 
a concentration of 20 mg/mL.  The PA in the six-well plates was polymerized on a flat 
surface under ultraviolet light (365 nm) for three minutes and thirty seconds.  The gels 
were then rinsed one time and stored in 1X PBS. 
 
Secondary Layer for Controlled Stiffness 
 Shortly after, twenty-two millimeter wide gels of PA were cast on top of the 
primary substrate (see Appendix O).  Eighty microliters of PA under a glass coverslip 
was used to create each gel.  The gels were sterilized under UV light for 10 minutes.  
This second layer of polyacrylamide used NHS-ester to incorporate Fibronectin (BD 
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Biosciences) into each gel. The gels were then incubated in sterile glycine overnight to 
quench the unreacted NHS. 
5.4 Validation of Stiffness 
 Previous groups have documented the stiffness values of PA gels created using 
the protocol from Yu Li Wang’s laboratory (see Appendix F) using atomic force 
microscopy (AFM) in both wet and dry testing. 
5.5 Validation of Stretch 
 To validate the amount of stretch attained in the latex membrane of our custom 
culture plate design, we used the triad method to determine the stretch achieved relative 
to the input stretch percentages of the Flexcell device.  Markers were placed on the 0.014 
inch thick latex using black ink in a pattern centered in the middle a cell culture well.  
The stretch achieved by the PA substrate on the latex membrane was also assessed using 
the triad method using graphite shards as markers on the polyacrylamide substrate. 
 Images were captured using a mobile imaging station (shown in Figure 25).  The 
workspace was shrouded using a black curtain to prevent glare from extraneous light 
sources.  The camera was positioned directly above the well of interest (~20cm), and a 
soft uniform light was cast on the well using a circular fluorescent bulb mounted on a 
ring stand.  A computer running SPOT Advanced Imaging software was used to control 
the camera and capture the images, which were saved as uncompressed TIFFs.  
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Figure 25:  Mobile imaging cart 
 
Images of each well were captured over a range of stretch levels, with input pressures of 
the flexcell device ranging from 0 kPa to ~55 kPa.  For each level of stretch, static 
vacuum pressure was applied, and sufficient time was allowed for the material to become 
stable (~30s). 
 After imaging, the centroid of each particle was found using Image J software 
made available by the National Institutes of Health (NIH) and the amount of strain in 
each direction as well as sheer strain was determined using displacement coordinates and 
the equation for Green’s strain: ds2 – dso2 = 2Eijdaidaj.  The complete protocol for triad 
analysis is shown in Appendix R. 
5.6 Validation of Homogeneity 
High Density Mapper (HDM) software was used to validate the homogeneity of the 
latex membrane to ensure that the cells in any given area within each well would 
experience the same stretch percentages.  The software was first used on the 0.014 inch 
latex and then on the PA with AIBN layer on the latex membrane.  Images for HDM 
analysis were taken using a 6.1 megapixel Nikon D50 digital camera with a linear 
resolution of 42 pixels/mm (1 pixel = 0.024 mm).  This camera was mounted on the same 
mobile imaging station used for the triad method (Figure 25). 
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5.7 Cell Culture 
 Human dermal fibroblasts (ATCC) were thawed and cultured in Dulbecco’s 
Modified Eagle’s Medium (DMEM culture medium) (Mediatech) supplemented with 
10% bovine calf serum (BCS) (HyClone) and 100 units/ mL penicillin G sodium (Gibco), 
100 μg/ mL streptomycin sulfate (Gibco), and 250 ng/ mL amphotericin B (Gibco).  
Valvular interstitial cells were cultured as above, except fetal bovine serum (FBS) was 
used instead of BCS.  The cell culture protocols followed for both fibroblasts and VICs 
are shown in Appendix P. 
5.8 Cell Seeding 
 Before seeding the cells, the PA substrates were equilibrated in 200 µL culturing 
medium for one hour at 37°C.  The cells were counted and seeded (see Appendix P) on 
Flexcell plates at 5,000 cells/well.  All plates were incubated overnight in DMEM 
culturing medium under static conditions in an 80-90% humid incubator at 37° C and 
10% CO2 to allow for initial cell attachment (Conforte et al., 2006).  Media was changed 
every two days. 
5.9 Application of Stretch 
 The plates were placed on the base plate of the Flexcell™® FX-4000T 
(Flexcell™ International, Hillsborough, NC).  This system applies uniform, equibiaxial, 
cyclic stretch to the substrate by applying vacuum pressure to pull the membrane over the 
loading posts as described in Chapter 2.  Upon measurement of the vacuum pressure and 
comparison with levels of stretch, the Flexcell™ device can provide the levels of stretch 
achieved.  Experiments were conducted at a frequency of one Hertz with a desired square 
wave function from 0 – 25% stretch on PA with levels of stiffness of 7 – 75 kPa for two 
days. 
5.10 Immunohistochemistry 
 Cell viability after stretching was determined using the LIVE/DEAD® 
Viability/Cytotoxicity Assay Kit (Molecular Probes) (see Appendix V). Cells were rinsed 
once with 1xDPBS, then the Live/Dead stain was applied for 35 minutes at room 
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temperature in the dark. After rinsing, six images from different regions of each well 
were taken with a Nikon Eclipse E600 inverted microscope and SPOT imaging using 
FITC and DAPI fluorescence. 
 Cell viability tests were also performed with each component of the cellular 
environment. This was done using the Transwell® plate system (Corning) in which cells 
were seeded on the permeable surface which was then inserted into the well containing 
the substance being tested for toxicity. This allowed the cells to be exposed to the solutes 
in the media that came from the substance without directly interacting with the substance. 
To evaluate cytotoxicity of the materials, the LIVE/DEAD® kit was used as described 
above. 
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Chapter 6:  Results 
This chapter summarizes the data collected for the validation of the designed 
method.  Representative data sets for validation of stretch using the triad method, 
validation of homogeneity using HDM software, validation of cell viability, and 
Transwell® toxicity analysis are located in each section. 
6.1 Validation of Stretch 
 To validate the amount of stretch attained in the latex membrane of our custom 
culture plate design, we used the triad method to determine the amount of stretch 
achieved relative to the input stretch percentages of the Flexcell Device.  Markers were 
placed on the 0.014 inch thick latex using black sharpie ink in a pattern centered in the 
middle of the cell culture well.  The stretch achieved by the PA substrate on the latex 
membrane was also assessed with the triad method using graphite shards as markers on 
the polyacrylamide substrate.  Marker placements on both the latex membrane and the 
PA on latex are shown in Figure 26. 
 
 
Figure 26:  Markers on latex (left) and polyacrylamide (right) 
     
 ImageJ Analysis software (V 1.37) was used to determine the pixel coordinates of 
each marker within each of the captured images.  The MATLAB® Programming 
Environment was used to create a program file to determine stretch in both x and y 
directions, as well as shear strain using Green’s strain equation (code in Appendix R).  
 43
The pixel coordinates of a set of three markers (triangle) were compared before and after 
stretch, calculating the change in linear distances in two dimensions.  In addition, this 
strain calculation code was also programmed into Microsoft Excel to simultaneously 
analyze and compute the strains for eight triangles, which are shown below in Figure 27.  
 
 
Figure 27:  Eight triangles within region of interest 
 
The protocol used for the entire triad method analysis is shown in Appendix R.  For latex 
analysis, a total of three wells were analyzed over 10 days of constant cyclic stretch at 
timepoints of 0, 3, 5, and 10 days (see results in Appendix X).  The average of membrane 
stretch for the three wells vs. input vacuum pressure during each day of testing at each 
time point is shown in Figure 28. 
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Figure 28:  Stretch achieved by latex using the triad method. 
Each point represents the average stretch percent achieved all three wells. 
 
For PA on latex analysis, a total of three wells were analyzed to show the 
consistency of stretch between wells.  The PA layer with AIBN was made according to 
Appendix N at a stiffness of about 33 kPa.  The stretched achieved by each PA substrate 
on the latex for each well vs. input vacuum pressure is shown in Figure 29. 
 
 
Figure 29:  Stretch achieved by PA on latex using the triad method. 
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6.2 Validation of Homogeneity 
High Density Mapper (HDM) software was used to validate the homogeneity of the 
latex membrane to ensure that the cells in any given area within each well would 
experience the same stretch percentages.  Representative results are shown in this section. 
6.2.1 Latex HDM 
   Static images of the latex membrane were taken at 0%, 2%, 4.5%, 6%, 7.5%, 
and 9% input strain from the Flexcell device which output actual strains ranging from 0-
19% based on triad analysis.  The output stretch percent of latex compared to the input 
stretch percent of the Flexcell device is shown in Figure 30. 
 
Figure 30:  Output stretch of latex vs. input stretch of the Flexcell device 
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The reasoning for taking each incremental stretch images is that HDM software can only 
accurately assess homogeneity in small stretch comparisons.  High density markers were 
made using black spray paint to make fine dots.  HDM data was obtained on latex using a 
600 x 600 pixel square in the center of the well (see Appendix S) which represents a 
14.29mm x 14.29mm square in the region of interest as shown in the well at 0% stretch in 
Figure 31. 
 
 
Figure 31:  Latex with spray paint for HDM analysis of the specified region 
 
The images were analyzed using a 64 x 64 pixel subsize image with a 16 pixel shift.  This 
allowed HDM to output a 35 x 35 data point set for both X and Y displacement data.  The 
data was then smoothed using MATLAB® software to remove outliers produced by 
noise or reflection in each image (see Appendix T).  The software also removed 
perimeter data points (5 points on each side of the matrices) to remove inaccurate edge 
points and those skewed in the 2D smoothing (producing 25 x 25 smoothed data matrices 
for strain analysis).  This protocol, as well as the method used to calculate X, Y, and 
shear strains are located in Appendix T.  The maximum, minimum, average, and standard 
deviation for a representative well is shown below in Table 7. 
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Table 7:  Exx, Eyy, and Exy strain results for each stretch comparison of latex 
Output stretch results were interpolated from the graph in Figure 30. 
 
0% to 2% Flexcell Input 
(~0-2% Latex Stretch)  
2% to 4.5% Flexcell Input 
(~2-5.6% Latex Stretch)  
4.5% to 6% Flexcell Input 
(~5.6-9% Latex Stretch) 
 εxx εyy εxy  εxx εyy εxy  εxx εyy εxy 
Max 2.12% 2.59% 0.48%  4.57% 4.60% 0.53%  3.22% 3.36% 0.42%
Min 1.46% 1.40% -0.39%  3.61% 3.54% -0.29%  2.50% 2.49% -0.28%
Mean 1.75% 2.02% 0.10%  3.97% 4.09% 0.10%  2.85% 2.99% 0.06%
Stdev 0.10% 0.18% 0.13%  0.17% 0.22% 0.15%  0.14% 0.18% 0.11%
Stdev/Mean 5.56% 8.87%    4.27% 5.35%    4.97% 6.01%   
 
 
6% to 7.5% Flexcell Input 
(~9-13.8% Latex Stretch)  
7.5% to 9% Flexcell Input 
(~13.8-18% Latex Stretch) 
 εxx εyy εxy  εxx εyy εxy 
Max 1.46% 1.37% 0.37%  2.97% 2.87% 0.35% 
Min 0.81% 0.57% -0.35%  2.03% 1.81% -0.48% 
Mean 1.15% 1.01% 0.02%  2.50% 2.35% 0.03% 
Stdev 0.13% 0.14% 0.12%  0.16% 0.25% 0.12% 
10.87% 14.14%    6.58% 10.55%   Stdev/Mean 
 
To show a visual representation of the homogeneity of the strain fields, SigmaPlot® 
software was used to make contour plots of the X, Y, and shear strain matrices previously 
calculated.  A sample contour plot of 3.97% incremental Exx stretch is shown below in 
Figure 32.  The consistency of yellow color with small variability validates homogeneity. 
  
Figure 32: Contour plot of Exx strain field of latex 
with ~3.97% incremental stretch 
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6.2.2 Polyacrylamide on Latex HDM 
Static images were taken following the same methodology used to take images for 
HDM analysis of latex to assess the homogeneity of the primary layer of PA with AIBN 
on the latex membrane.  High density markers were made using ground graphite particles 
to make fine dots.  HDM data was obtained on latex using a 600 x 600 pixel square in the 
center of the well which represents a 14.29mm x 14.29mm square in the region of interest 
as shown in the well at 0% stretch in Figure 33. 
 
 
Figure 33:  PA on Latex with graphite for HDM analysis of the specified region 
 
The images were analyzed using a 64 x 64 pixel subsize image with a 16 pixel 
shift.  This allowed HDM to output a 35 x 35 data point set for both X and Y 
displacement data.  The data was then smoothed using MATLAB® software using the 
same smoothing method applied to latex data.  This protocol, as well as the method used 
to calculate X, Y, and shear strains are located in Appendix T.  The maximum, minimum, 
average, and standard deviation for a representative well is shown below in Table 8. 
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Table 8:  Exx, Eyy, and Exy strain results for each stretch comparison of PA on latex 
Output stretch results were interpolated from the graph in Figure 30. 
 
0% to 2% Flexcell Input 
(~0-2% Latex Stretch) 
2% to 4.5% Flexcell Input 
(~2-5.6% Latex Stretch) 
4.5% to 6% Flexcell Input 
(~5.6-9% Latex Stretch) 
 εxx εyy εxy εxx εyy εxy εxx εyy εxy 
Max 5.94% 6.46% 0.78% 4.98% 5.31% 0.53% 3.46% 3.61% 0.28%
Min 4.27% 4.13% -0.66% 3.14% 3.68% -0.60% 2.89% 3.03% -0.26%
Mean 5.23% 5.30% -0.02% 4.27% 4.35% -0.05% 3.16% 3.31% 0.01%
Stdev 0.30% 0.34% 0.25% 0.24% 0.23% 0.20% 0.09% 0.11% 0.10%
Stdev/Mean 5.65% 6.32%   
   
 
 
 
 
  
  
  
  
  
 
 
5.60% 5.37%    2.98% 3.47%   
 
 
6% to 7.5% Flexcell Input 
(~9-13.8% Latex Stretch) 
7.5% to 9% Flexcell Input 
(~13.8-19% Latex Stretch) 
 εxx εyy εxy εxx εyy εxy 
Max 3.37% 3.57% 0.23% 3.74% 3.59% 0.40% 
Min 2.88% 2.88% -0.25% 2.86% 2.72% -0.39% 
Mean 3.10% 3.23% -0.01% 3.26% 3.08% -0.01% 
Stdev 0.09% 0.12% 0.08% 0.15% 0.16% 0.13% 
 
 
 
 
 
 
 2.92% 3.82%   4.74% 5.25%   Stdev/Mean 
 
SigmaPlot® software was used to make a representative contour plot of 3.23% 
incremental Eyy stretch shown below in Figure 34. 
 
 
Figure 34:  Contour plot of Eyy strain field of PA on latex 
with ~3.23% incremental stretch 
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6.3 Validation of Cell Viability and Attachment 
In order to validate that the cells would be able to live in the environment of our 
designed method, extensive validation of cell viability was completed using the 
Transwell® plate system (Corning).  Attachment of VICs to the secondary cell interaction 
layer was also validated.  Each layer shown in Figure 35 was tested individually. 
 
Figure 35:  Substrate design 
 
6.3.1 Cell Attachment 
The stiffness tunable/cell interaction layer of PA with APS initiator and NHS-
ester/fibronectin was tested for cell attachment using cultured porcine valvular interstitial 
cells.  The protocol for isolating VICs is shown in Appendix W.  This secondary layer 
was made according to the protocol in Appendix O at both low and high stiffness levels.  
The porcine VICs were seeded on each gel, and phase contrast images were acquired 
after 24 hours.  These images are shown in Figure 36. 
 
(a)      (b)  
Figure 36:  Porcine VICs attached to PA with APS (courtesy of Angela Throm) 
a) 8/0.02% acryl:bis (low stiffness) b) 8/0.08% acryl:bis (high stiffness) 
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6.3.2 Cell Viability 
The toxicity of the PA with APS initiator (no fibronectin or NHS-ester), PA with 
AIBN initiator, medical grade adhesive, and the latex membrane were tested using 
cultured human dermal fibroblast cells in Transwell® plates.  Cell viability was assessed 
after 24-29 hours using the LIVE/DEAD® Cytotoxicity Assay, where green signifies the 
live body of the cell and red signifies the nucleus of a dead cell.  Three samples were 
used for each experiment.  Representative results for the polyacrylamide and adhesive 
can be seen in Figure 37. 
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a) Medical grade adhesive b) PA with APS (7 kPa) 
    
 c) PA with AIBN – no rinsing d) PA with AIBN – 3 hours rinsing 
  
 e) Control (no additives) f) Latex 
  
 
Figure 37: Dermal fibroblasts in Transwell® plates exposed to various 
elements of the cellular environment (Magnification: 200X) 
 
 Cells exposed to latex and the PA with AIBN that was not rinsed expressed 
different characteristics than the control cells.  The cells exposed to latex were not 
attached to the surface and dying (expressing both green and red colors). The cells 
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exposed to PA with AIBN were slightly smaller in size and less dendritic than the control 
cells.  However, unlike the cells exposed to latex, these cells were alive. 
 It was soon determined that extensive leeching of the proteins from the latex 
membrane would be necessary.  For these tests, the latex was first rinsed in DI water for 
four days with a nearly constant flow of water through a beaker in which the latex was 
rinsed.  The latex was then rinsed for one day in DMEM with 10% BCS. This media was 
changed twice.  Results from these latex tests can be seen in Figure 38.
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 Figure 38: Dermal fibroblasts in Transwell® plates exposed 
to various rinsing stages of latex (Magnification: 200X) 
  
a) Latex – no rinsing b) Latex – four days DI rinsing 
    
 c) Latex – four days DI and one day  
  media rinsing (phase contrast) d) Latex – 3 hours rinsing 
  
 e) Control (no additives) (phase contrast) f) Control (no additives) 
 
 Though rinsing the latex with DI water alone did not keep the cells alive for over 
24 hours in the Transwell® plates, the cells were spread and attached to the surface longer 
than the cells exposed to the non-rinsed latex.  Rinsing the latex in media following the 
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four-day rinse in DI water allowed the cells to stay spread and attached to the Transwell® 
membrane, exhibiting similar morphology to that of the control cells. 
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Chapter 7:  Analysis and Discussion 
 The designed method for applying controlled levels of stiffness and stretch to cell 
culture substrates was successfully validated.  This assessment proved that our developed 
client statement of applying stretch levels from 0-20% and stiffness levels of 7-75 kPa 
was possible using a latex membrane, PA with AIBN for covalent attachment, and PA 
with APS and fibronectin for cell adhesion.  Validation of each layer for analyzing cell 
viability confirmed the completion of design requirements.  This chapter discusses the 
results of stretch, homogeneity, and cell viability validations. 
7.1 Validation of Stretch 
 Triad analysis of the latex membrane confirmed the amount of stretch attained in 
the latex membrane of our custom culture plate design relative to the input stretch 
percentages of the Flexcell Device.  Results from stretching the latex over the 10 day 
period revealed fatigue of the membrane in response to cyclic stretch.  The majority of 
material fatigue occurred within the first three days, decreasing from ~20% stretch to 
~17% stretch at ~50kPa (Δ15%).  Therefore, the latex should be preconditioned for three 
days to achieve consistent strains during experiments.  The relationship between input 
vacuum pressure and output material stretch remained consistent throughout testing.  
Both the latex membrane and polyacrylamide transition layer stretched at a higher rate as 
vacuum pressure increased above ~40kPa. 
 Our specific region of interest was in the center of the wells (~16mm2), where the 
cells reside during culture.  Eight separate triangles were used, and the standard deviation 
within strain of all triangles was found to be 1.26%, when 15.8% strain was applied to the 
latex membrane.  This shows that similar strains were applied to all areas throughout the 
region of interest. 
 The calculated membrane stretch of the polyacrylamide substrate attached to the 
latex membrane was within 12% of the output stretch of the latex membrane at 40 kPa.  
This increase in stretch percent can be attributed to vacuum regulation, marker 
characteristics, and/or increase in material thickness.  However, the strain percents 
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achieved were shown to be consistent between each well of polyacrylamide (SD 1.4% at 
40 kPa). 
7.2 Validation of Homogeneity 
The results produced using HDM software confirmed that both the latex membrane 
and the PA substrate were both undergoing relatively homogeneous equibiaxial stretch.  
Since HDM was used specifically to assess the homogeneity of the strain field and not 
the actual stretch percent achieved, the differences in the average stretch percentages 
(Exx, Eyy, and Exy) for latex and PA on latex were not a validation issue.  These 
differences were contributed to glare on the images, marker density, and/or possible 
software error.  The triad method previously discussed quantified the actual stretch 
percents achieved.  HDM analysis was solely used for the purpose of showing equibiaxial 
stretch.  The use of MATLAB® software removed obvious outliers and 2D smoothed the 
data sets to lessen data error caused by noise. 
Since each image was analyzed using a 64 x 64 subimage pixel size with linear 
resolution of 0.024 pixels/mm, each subimage allowed a data point in HDM software for 
every 1.54 mm x 1.54 mm area.  The 16 pixel shift applied to this subimage size, 
therefore means that HDM essentially provided a data value for every 0.39 mm in the 
region of interest. 
The Exx and Eyy average strain values for the each stretch comparison (inputs of 0-
2%, 2-4.5%, 4.5-6%, 6-7.5%, and 7.5-9%) of both latex and PA on latex were shown to 
be close with small standard deviations.  This shows that both the latex and the PA on the 
latex undergo equibiaxial stretch.  A representative example for Exx strain shown in the 
results is 3.97% ± 0.17%.  This standard deviation represents 4.27% of the mean value.  
Values for standard deviation percentage of the mean ≤ 20% were considered good, while 
values ≤ 10% were considered excellent.  For latex, each standard deviation percentage 
of the mean was ≤ 14.14%.  For PA on latex, each standard deviation percentage of the 
mean was ≤ 6.23%.  Shear strain for each representative data set shown in the results 
section was close to 0.00% meaning that shear strain of the latex membrane and PA on 
latex was negligible. 
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7.3 Validation of Cell Viability and Attachment 
 The toxicity tests conducted signified no danger in culturing cells in the presence 
of the medical grade adhesive and PA with APS.  Fibroblast cells were alive and spread 
in both conditions, as well as in the control, which was exposed to no external factor 
other than the media.  Cells exposed to PA with AIBN that was not rinsed exhibited a 
slightly smaller cell spreading area.  However, after rinsing, this adverse effect 
disappeared.  Rinsing of the primary layer of PA will therefore be necessary. When 
cultured in the presence of latex, the fibroblast cells detached from the surface and died. 
This was avoided (for 29 hours) by rinsing the latex in DI water extensively then in 
media for one day.  Further investigations will determine a quicker and more efficient 
method of leeching the latex so it is safe for use with cells over three days.  Though the 
leeching of the latex needs to be further investigated, the overall designed method has no 
adverse effects on cell viability after one day. 
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Chapter 8:  Conclusions 
 
A method to apply controlled levels of stiffness and stretch to cell culture 
substrates was successfully completed.  All accomplished aims and tasks previously 
discussed in our project approach were benchmarks necessary for the method design.  
Using the Flexcell equibiaxial stretch device with a latex membrane, cyclic strains similar 
to in vivo conditions can be applied to cell culture environments.  The attachment of a 
polyacrylamide substrate with modifiable stiffness levels to the latex membrane signified 
the first method to apply controlled stiffness and stretch simultaneously to a cellular 
environment, which more accurately models in vivo conditions than previous studies. 
Each component of the developed method was validated to quantify the actual 
mechanical parameters (stretch, stiffness, and homogeneity) applied to the cell growth 
environment.  In addition, the cell viability of each component was assessed, and cell 
attachment to the secondary PA layer was verified. 
 This method will be applied in future research to study VIC mechanobiology 
under normal and pathological conditions.  Knowledge from these studies can improve 
heart valve treatment options and aid in the design of biologically active replacements. 
Additional impact of this developed method extends into the realm of tissue engineering 
and stem cell research.  This method presents an in vitro research technique that more 
accurately represents in vivo conditions, allowing the application of additional parameters 
to study tissue response and stem cell differentiation. 
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Chapter 9:  Recommendations 
 This chapter discusses the suggestions that may improve the designed project 
method.  The following recommendations include ideas for validation and cell adhesion 
as well as design ideas that may facilitate the plate assembly process.  Applications of 
these suggestions could improve the method to study the extent of the combined effects 
of controlled levels of stiffness and stretch on cell response. 
Improving the plate design could make the process for assembly less timely and 
more consistent.  Based on our time constraints, we did not have time to manufacture a 
new plate.  However, CAD software could be used to design similar plates that could be 
manufactured out of an autoclavable material such as polysulphone, UHMWPE, or 
stainless steel.  An example of a possible designed plate is shown below in Figure 39. 
 
Figure 39:  Possible CAD culture plate 
 
Improving the pre-stretch device through the use of machined device elements 
would increase sterility and improve the consistency of latex pre-stretch.  This would also 
decrease preparation time. 
Preconditioning of the latex for three days to achieve consistent strains during 
experiments. 
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 Using an alternative membrane for stretch could eliminate possible protein 
leaching.  Alternative sources of latex with less proteins incorporated into their raw 
material are an additional option. This would shorten preparation time as well as ensure 
less risk of toxicity for the cells.  The material would need to have comparable fatigue 
resistance and isotropic stretch characteristics achieving at least 20% elongation.  The use 
of a clear membrane would also facilitate image analysis. 
 The application of different leaching methods for latex could possibly remove 
more proteins than soaking the latex in water.  A specified leaching time period would 
provide a more standardized latex leaching process where the maximum amount of 
proteins could be removed while minimally disturbing the properties of the latex itself. 
Applying our method to different cells besides fibroblasts and VICs to study the 
effects of stiffness and stretch would extend the value of this method.  Pulmonary 
fibroblasts, for example, also endure cyclic stretch and increased levels of stiffness in 
diseased states.  The abnormal differentiation of these cells is a common feature in many 
different fibrotic diseases.  The triggers that cause this response are also poorly 
understood.  The application of our designed method with other cell types allows other 
researchers and future project groups to expand knowledge about the effects of 
mechanical stimuli on cells throughout the body. 
Improving the sterility of the final plate would allow the experiments to run for 
a longer period of time with decreased risk of cell contamination.  Currently, the 
materials used for the custom plate do not facilitate easy and complete sterilization. 
 Manufacturing a custom plate with appropriate material for autoclaving or obtaining a 
means to perform a different method of sterilization would allow a more complete 
sterilization. 
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Glossary 
 
Alpha smooth muscle actin (aSMA) (n.) – cell differentiation marker resulting from 
mechanical stimulus 
 
Anisotropic (adj.) – having unequal physical properties in different directions 
 
Bioprosthetic (n.) – artificial replacement made from treated biological tissue 
 
Extracellular matrix (ECM) (n.) – substance that makes up connective tissue; made up 
of glycoproteins, proteoglycans, and hyaluronic acid 
 
Hydrophilic (adj.) – having an affinity for water 
 
Hydrophobic (adj.) – having little affinity for water 
 
Immunohistochemistry (n.) – the process that involves staining antibodies to locate 
specific antigens in tissue 
 
Morphology (n.) – form and structure 
 
Myofibroblast (n.) – a fibroblast cell with contractile properties 
 
Pathological (adj.) – pertaining to disease 
 
Phenotype (n.) – physical traits and appearance 
 
Stenosis (n.) – the narrowing of a valve or vessel to the point of decreased flow 
 
Thromboembolism (n.) – the blocking of a vessel from a thrombus, or blood clot 
 
Valvular interstitial cell (VIC) (n.) – the most prominent cell in valve leaflets responsible 
for maintaining structural integrity 
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Appendix A:  Preliminary Interviews 
Interviewee: Professor Shivkumar  Date: 9/13/06   Time: 12:00 pm 
 
1. Do you have any recommendations of how to attach polyacrylamide to a silicone or 
PDMS surface? (any way to “activate” the silicone or PDMS to allow a hydrogel (PA) to 
attach to it) 
 
PA depends on a lot of things such as molecular weight and crosslink density.  At 
variations of these, you might be able to attach PA to attach to the substrate.  However, PA 
absorbs a lot of water, but this can be controlled by controlling the crosslink density with 
certain alloys. 
 
2. Do you know any pertinent qualities of HEMA? 
 
HEMA is one of the best hydrogels (hydrophilic).  It is used in soft contact lenses.  There 
has to be research already done on attaching HEMA to silicone.  Look at the polymer 
handbook in the library, or any book on hydrogels. 
 
3. How toxic would the PDMS be if it were not fully polymerized (not enough of one 
of the two components) 
 
If PDMS is not fully polymerized, this means that it has not crosslinked completely.  
Therefore, this is very toxic to cells, as the 80:1 PDMS you have there most likely is.  The 
toxicity depends on the amount of unreacted monomer and any active/reactive groups.  
Look at the polymer handbook in the library. 
 
4. At any point, is it possible for non-homogenous portions of PDMS or PA be 
formed during polymerization? (lumps in the mixture) 
 
Yes, unless it is blended well.  There are mixing chambers you could buy that could help.  
You could also add a catalyst to the mixture to speed up the process.  (heat would still have 
to be applied)  It would be a good idea to looking into the time and temperature 
recommendations for the preparation process from the company that you get your PDMS 
from. 
 
5. Do you have any idea on ways to get cells to adhere to PA? 
 
I’m not really sure, it depends on the cells because PA absorbs so much water.  About 60% 
of cells don’t like materials that are 100% hydrophilic.  Fibroblasts prefer moderate 
hydrophilic/hydrophobic conditions.  A lot of things also influence the qualities of PA.  For 
example, the pH, enzymes, and bacteria will all have an effect on adhesion. 
 
6. How long will PA last if we were to keep it for 2 weeks? 
 
The properties should remain the same in 2 weeks.  If you see browning of the material, 
this is a sign of changing properties. 
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Appendix B:  Brainstorming Session 
Present:  Professor Billiar, Professor Pins, Angela Throm, Jenna Balestrini, Cathryn 
Bedard, Mike Drnek, Leslie Sierad 
 
 
 
Stretchable 
Materials 
Stretch 
Characteristics 
Durable 
Accept 
Cells or 
Substrate 
Layer 
Conclusion 
Latex Elastic (linear)    
Bubble Gum Non-Elastic   No 
Rice Paper  No   
Elastin     
pHEMA     
Nitrile     
Poly 
Urethane     
Rubber 
Cement  No  No 
Rubber     
Spring 
Material   No No 
Cotton  No No No 
Plastic Wrap  No No No 
Parafilm Non-Elastic No  No 
Wax Non-Elastic No  No 
Trampolines   No No 
Mesh  No No No 
SIS-UBM     
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Appendix C:  Pairwise Comparison Charts 
 
Client 1:  Professor Billiar 
 
Objectives 
PCC 1 User Friendly Adaptable Durable Inexpensive
Time 
Efficient SCORE
User 
Friendly XXX 0 1 1 1 3 
Adaptable 1 XXX 1 1 1 4 
Durable 0 0 XXX 1 0 1 
Inexpensive 0 0 0 XXX 
 
 
 
 
Objectives: Effectiveness 
PCC 2 
1 1 
Time 
Efficient 0 0 1 0 XXX 1 
Cell 
Viability Repeatable 
Stretch 
Range 
Stiffness 
Range 
Cell 
Adhesion 
Assay 
Compatible SCORE 
Cell 
Viability XXX 0 1 1 1 1 4 
Repeatable 1 XXX 1 1 1 1 5 
Stretch 
Range 0 0 XXX 0 0 0 0 
Stiffness 
Range 0 0 1 XXX 0.5 0.5 2 
Cell 
Adhesion 0 0 1 0.5 XXX 1 2.5 
Assay 
Compatible 0 0 1 0.5 0 XXX 1.5 
 
 74
Client 2:  Angela Throm 
 
Objectives 
PCC 1 User Friendly Adaptable Durable Inexpensive
Time 
Efficient SCORE
User 
Friendly XXX 1 1 1 0 3 
Adaptable 0 XXX 1 1 0 2 
Durable 0 0 XXX 1 0 1 
Inexpensive 0 0 0 XXX 0 0 
Time 
Efficient 1 1 1 1 XXX 4 
 
 
Objectives: Effectiveness 
PCC 2 Cell Viability Repeatable
Stretch 
Range 
Stiffness 
Range 
Cell 
Adhesion
Assay 
Compatible SCORE
Cell 
Viability XXX 1 1 1 1 1 5 
Repeatable 0 XXX 1 0 0 1 2 
Stretch 
Range 0 0 XXX 1 0 1 2 
Stiffness 
Range 0 1 0 XXX 0 1 2 
Cell 
Adhesion 0 1 1 1 XXX 1 4 
Assay 
Compatible 0 0 0 0 0 XXX 0 
 
 
 75
Totals with Group Scoring Included 
 
Objectives 
  Professor Billiar 
Angie 
Throm
Mike 
Drnek
Cathryn 
Bedard 
Leslie 
Sierad Average 
Weighted 
Percentage
User 
Friendly 3 3 3 1 3 2.75 27.50 
Adaptable 4 2 0.5 4 1 2.44 24.38 
Durable 1 1 2.5 2 2 1.44 14.38 
Inexpensive 1 0 0.5 0 0 0.31 3.13 
Time 
Efficient 1 4 3.5 3 4 3.06 30.63 
Totals 10 10 10 10 10 10 100 
 
Objectives: Effectiveness 
  Professor Billiar 
Angie 
Throm
Mike 
Drnek
Cathryn 
Bedard 
Leslie 
Sierad Average 
Weighted 
Percentage
Cell 
Viability 4 5 3.5 3 5 4.31 28.75 
Repeatable 5 2 2.5 3.5 2.5 3.06 20.42 
Stretch 
Range 0 2 2.5 2 2.5 1.63 10.83 
Stiffness 
Range 2 2 2.5 2.5 2.5 2.19 14.58 
Cell 
Adhesion 2.5 4 3.5 2 1.5 3.00 20.00 
Assay 
Compatible 1.5 0 0.5 2 1 0.81 5.42 
Totals 15 15 15 15 15 15 100 
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Appendix D:  Decision Matrix Reference Key 
 
Constraints Flexcell 4,5,6,7,8,9 Tschumperlin 1 Butcher 10 Lee 2 Winston 3 
Cost < ~$2000 Yes  No   
Fit inside incubator Yes No  No No 
< 3 hour set up Yes     
Cell attachment Yes     
Stretch 2-20% Yes     
Run for 2 days Yes     
 Multiple samples Yes    
 User Independent Yes   
*The first “No” indicated no need for further matrix analysis. 
 
 
Devices: 
1 - (Tschumperlin et al., 1998) 
2 – (Lee et al., 1996) 
3 – (Winston et al., 1989) 
4 – (Brown,2000). 
5 – (Flexcell International Corp.,2003). 
6 – (Balestrini et al., 2006) 
7 – (Von Offenberg Sweeney et al., 2005) 
8 – (Shelton et al., 2006) 
9 – (Morrow et al., 2005) 
10 – (Butcher et al., 2006) 
 
Substrates: 
1 – (Bensaid et al., 2003) 
2 – (Cleland et al., 1984) 
3 – (Kobayashi et al., 2005) 
4 – (Leor et al., 2000) 
5 – (Patricia M. Taylora, Anthony E.G. Cassb and Magdi H. Yacouba,2006) 
6 – (Aoki et al., 2004) 
7 – (Normand et al., 2000) 
8 – (Thierry et al., 2005) 
9 – (Engler et al., 2004b) 
10 – (Pelham et al., 1998) 
11 – (Yeung et al., 2005) 
12 – (Mizuno et al., 2006) 
13 – (Petrini et al., 1999) 
14 – (Peterson et al., 2005) 
15 – (Sakkers et al., 1998) 
16 – (Karabanova et al., 2006) 
17 - (Hahn et al., 2006b; Hahn et al., 2006c; Underhill et al., 2007) 
18 - (Underhill et al., 2007) 
19 - (Ghosh et al., 2007; Hahn,2006) 
20 - (Hahn,2006) 
21 - (Hahn et al., 2006a) 
22 - (Semler et al., 2005) 
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Appendix E:  Possible Substrate Attachment Designs 
 
Several preliminary designs were developed using various techniques of 
intermediary material and substrate attachment.  Extensive testing and validation of each 
device was performed prior to choosing the final design.  Methods including substrate 
casting and application, circular intermediary material application, and mechanical 
attachment using posts are discussed below. 
 
Design 1: Base & Cast Elements 
 A designed device to facilitate consistent and simple substrate casting 
independent of the Flexcell plate was considered, using a base with removable casting 
elements.  The gels can be cast on glass and inside a PPE ring on the casting elements as 
shown in Figure 40.  After polymerization, silicone adhesive is applied to the PE ring for 
attachment to the silicone membrane.  As shown, the base contains grooves that 
corresponding to the top of the Flexcell plate, which can be flipped over and fitted onto 
the base and casting elements.  This allows easy seating and alignment of the device and 
plate during application.  Each casting element is sized specifically to accommodate a 
circular ring of intermediary material, and takes into account the thickness and width of 
the bottom cover slip.  The height of the casting elements is such that when the Flexcell 
plate is placed over it, the silicone membrane comes in contact with the silicone adhesive 
applied to the intermediary material and substrate.  After the adhesive cures, it is 
hypothesized that the Flexcell plate can be lifted off of the case elements and base with 
the PE ring, and thus substrate, attached. 
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Figure 40:  Base and cast device design 
 
Version 1 of the casting element was modified after consulting with Professor 
Kristen Billiar.  Specific changes were implemented in Version 2, notably to the contact 
surface of the substrate, making the bottom substrate surface even with the bottom of the 
intermediary material.  Additionally, each casting element was lowered slightly into the 
base, to provide quick and easy alignment with the Flexcell plate during application. 
Based on initial testing of substrate attachment using circular rings of porous 
polyethylene, several design elements require reconsideration.  It is necessary to fully 
attach the PE to the silicone membrane prior to introduction of PEGDA, as the liquidous 
gel otherwise interferes with the curing of the silicone glue. 
 
Design 2: Circular Cutting and Application Device 
An alternative method of intermediary material attachment using a device serving 
as a simultaneous applicator and intermediary material cutter was devised (see Figure 
 79
41).  This device would cut the specified inner and outer diameters of sheeted post 
material, while concurrently cutting divisions within the resulting ring.  These eight 
divisions will be equally spaced, and allow for expansion during stretch.  The ring of 
sheeted intermediary material will be easily covered with medical grade silicone adhesive 
while in the device and then applied to the silicone sheeting.  The alignment of the 
intermediary material to the membrane will be dictated by the outer diameter of the 
circular cutting and application device, which will correlate to the diameter of the well. 
 
 
Figure 41:  Circular intermediary material cutting and application device design 
 
Design 3: Post Casting Plates 
To create posts formed at an angle outward from the center of the well, a casting 
element divided into four sections was designed.  This would allow the casting element to 
be easily removed from the well after the intermediary material was fully cured.  As 
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shown in Figure 42, this design creates each post with a filleted base to decrease stress 
concentrations.   
To cast posts with a larger cross sectional area at the top, a plate divided into eight 
or more sections is required, with posts at the junction of sections.  Without divisions in 
the casting plate, the plate would be impossible to remove without separating the cast 
material from the membrane.  This design is shown in Figure 43. 
 
Figure 42:  Plate design for casting substrates - angled outward 
 
 
Figure 43:  Plate design for casting substrates - larger top 
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Appendix F:  Yu-Li Wang’s Polyacrylamide (PA) Protocol  
Source: Yu-Li Wang Laboratory     January 4, 2006 
 
Materials: 
• No. 1 Coverslip, 45mm and 22mm circular (Special ordered from Germany) 
• 1x PBS 
• HEPES 1 M, pH 8.5, 1 mL 
• HEPES 50 mM, pH 8.5, 500 mL 
• Acrylamide(40%) and Bis (2%) (Biorad) 
• Ammonium Persulfate; 10mg in 100μl distilled water. Prepare immediately 
before gel polymerization step 
• TEMED 
• Sulfo-SANPAH; 400 ul/dish at 0.5 mg/ mL.  Add 1 μl DMSO per 1 mg of sulfo-
SANPAH.  Use HEPES 50mM at room temperature to bring to final volume. 
• Fibronectin (5ug/cm2). From the dry FN, resuspend in ddh2O at 1 mg/ mL. 
Aliquot into 2 mL microcentrifuge tubes with 80 µL per tube. Each aliquot is 
enough for four 22mm diameter substrates.  Add 720 μl to each 80 μl aliquot and 
use 200µLper each substrate. 
 
Acrylamide Preparation: 
• Make acrylamide solution in a 25 mL glass beaker according to the chart at the 
end of protocol. (if microbeads are required, replace 50 μl of the water with 50 μl 
of beads-sonacate beads for 1-2 min prior to adding to the solution) 
• Place beaker in vacuum jar and degas solution for ~5 minutes. NOTE: Depending 
on the strength of your vacuum, the solution may start to bubble over or freeze. If 
this happens, RELEASE THE VACUUM SLOWLY! 
• Add 30 μl ammonium persulfate and 20 μL TEMED to the acrylamide solution; 
mix gently. 
• Pipet 20 μl onto activated coverslip and quickly place a 22 mm circular coverslip 
over acrylamide. 
• Leave remaining acrylamide in beaker.  Once acrylamide in beaker has 
completely polymerized (about 30 minutes), assume that acrylamide in the plates 
has also polymerized. 
• Flood the bottom of the dish with ~2 mL of 50 mM HEPES to assist in the 
removal of the 20 mm coverslip.  
• Remove 20mm coverslip by popping it off with a scalpel. Substrates can now be 
stored in PBS for 2 weeks at 4°C. 
 
 
 
 
 
 
 
 82
Final Acryl/Bis 40%Acrylamide 2%Bis 1M HEPES H20+Beads Young's Modulus
8%/0.1% 1000 ul 250 ul 50 ul 3700 ul ?? kN/m2 
8/0.08 1000 200 50 3750 75 
8/0.06 1000 150 50 3800 30 
8/0.05 1000 125 50 3825 23 
8/0.04 1000 100 50 3850 17 
8/0.03 1000 75 50 3875 14 
8/0.02 1000 50 50 3900 10 
5/0.12 625 300 50 4025 33 
5/0.10 625 250 50 4075 28 
5/0.08 625 200 50 4125 24 
5/0.06 625 150 50 4175 15 
5/0.05 625 125 50 4200 ?? 
5/0.025 625 63 50 4262 7 
3/0.10 375 250 50 4325 ?? 
 
Acrylamide Activation: 
• Remove as much liquid as possible without drying out the substrate.  Add 200 μl 
Sulfo-SANPAH to substrate. 
• Place on UV box for 6 minutes.  Solution will become reddish brown when 
activated. 
• Remove Sulfo-SANPAH and rinse with 50 mM HEPES 
• Add 200 μl Sulfo-SANPAH. 
• Place on UV box for 6 minutes. 
• Remove Sulfo-SANPAH. 
• Wash with 50 mM HEPES and then flick off excess liquid. 
• Add 200 μl fibronectin to substrate and shake overnight at 4°C. 
• Rinse and store in PBS at 4°C for up to one week. 
• Before plating, expose the gel to UV for 15 minutes. 
• Replace PBS with complete culture medium. Place in incubator for 1 hour to 
allow equilibrium.  
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Appendix G: Poly(ethylene) Diacrylate (PEGDA) Protocol  
 
Poly(ethylene glycol) Protocol for Making Hydrogels of Various Stiffness for Cell 
Adhesion 
 
KLB-0601 
 
(1)  Preparation and Purification of PEG Diacrylate (PEGDA) 
 
Day 1 – Preparation 
 
Materials 
500 mL Round Bottom Flask 
#22 Glass Stopcock 
PEG powder of desired MW 
95172 BioChemika Ultra, 20,000 (Fluka) 7-10 kPa hydrogel 
81253 BioChemika Ultra, for molecular biology, 6,000 (Fluka) ~60 kPa hydrogel 
 
Procedure 
1. Place 2-4 moles of PEG in each of a glass beaker and pull vacuum to dry overnight.  
It absence of residual water is important to the quality of resultant PEGDA. 
2. Dry glassware overnight in the 100°C oven. 
 
Day 2 – PEG Acrylation 
 
Materials 
Acryloyl Chloride (MW = 90.51g/mol; ρ = 1.114 g/ mL; storaged in flammables 
refrigerator) 
Triethylamine (TEA; MW = 101.19 g/mol; ρ = 0.726 g/ mL) 
Argon Gas 
DCM (anhydrous) 
DCM (99%) 
2, 3 mL Glass Syringes; 1, 10 mL syringe (rinse before and after with DCM 99%) 
Stir bar 
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Procedure 
 
To make 12g of PEGDA: 
Yield (with 75% 
recovery)   PEG Acryloyl Chloride Triethlamine 
12g .650 mL .558 mL 9g = 15 plates* 6000 MW 
12g .195 mL .167 mL 9g = 15 plates* 20,000 MW 
 
To make 6g of PEGDA: 
Yield (with 75% 
recovery)   PEG Acryloyl Chloride Triethlamine
6g .325 mL .279 mL 4.5g = 7.5 plates* 6000 MW 
6g .098 mL .084 mL 4.5g = 7.5 plates* 20,000 MW 
*assuming 1 mL of PEGDA on each well in each Flexcell plate 
 
For each PEG batch: 
1. Obtain a round bottom flask with a glass stopcock and titration dial.  Evacuate and 
inert with argon gas (Ar) 3 times. 
2. Add PEG with Ar still flowing into the flask.  Evacuate and inert with Ar again. 
3. For 6g PEG, use a syringe to add 2.5 mL at a time anhydrous DCM 20 mL DCM 
per 6g PEG We want enough DCM to dissolve the PEG but we don’t want it to be 
too viscous.  When 5 mL DCM has been added, start stirring the mixture with the 
stir bar. 
4. Evacuate and inert with Ar again. 
5. Add TEA.  Evacuate and inert with Ar.  Allow solution to mix for 5 min. 
6. Add acryloyl chloride very slowly.  Evacuate and inert with Ar.  
7. React overnight, at least 12 hrs. 
 
Day 3 – PEG Diacrylate Precipitation. 
 
Materials 
1 L beaker 
Buchner Funnel 
Filter paper 
Diethyl ether 
 
Procedure 
1. Precipitate PEGDA out of solution with Diethyl Ether.  For 6g of PEGDA, start 
with a .5L beaker, 0.425L diethyl ether, and a stir bar.  While stirring the ether, pour 
in PEGDA solution.  PEGDA will precipitate as a white crystal.  Let the mixture 
stir for 10 min to move the TEA to the organic phase. 
2. Pre-wet filter with ether.  Filter to separate PEGDA. 
3. Dry thoroughly in air overnight and then under a vacuum.  PEGDA may be crushed 
with a mortar and pestle to get a finer powder, but don’t overcrush or it will be too 
dense. 
4. Store powder at -20°C until ready to use.  Expect a ~75% recovery. 
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Clean-up 
1. Dispose of the aqueous phase from the separation funnel down the sink in the hood 
while running lots of water. 
2. All ether waste goes in the ether waste disposal container in the flammables cabinet. 
3. Allow DCM to evaporate from all materials several hours to overnight before 
removing them from the hood and cleaning them. 
 
(2)  Preparation of ACRL-PEG-RGD 
 
1. Remove the PEGDA from -20°C and allow to warm FULLY to room temperature 
prior to opening. 
2. React the PEGDA with a THIOL terminated RGDC at a 1:1 molar ratio in 
triethanolamine (TEAO)-buffered saline (0.3M TEAO, 150 mM NaCl, pH 8.0) for 
1 hour at 37°C. 
3. Purify by dialysis with the same MW membrane. 
4. Store powder at -20°C until ready to use. 
 
(3)  Preparation of a 10% PEGDA Solution 
 
1. Remove your PEGDA from -20°C and allow to warm FULLY to room temperature 
prior to opening (depending on size of the bottle, give 30 min-1 hr) 
2. Remove your initiator solution plus separate NVP if needed and warm FULLY to 
room temperature (give at least 30 minutes).  
 
To Make NVP Solution (Acetophenone) for UV Polymerization*: 
• 300 mg of 2,2-Dimethoxy-2-phenylacetophenone 
• 1 mL of 1 vinyl-2-pyrrolidinone 99+% (NVP) 
In a glass vial, mix these components until total dissolution of the 2,2-Dimethoxy-2 
phenylacetophenone. Store at 4°C. 
 
To Make Eosin Y Solution for White Light Polymerization*: 
• Weigh out eosin Y so that your final solution will contain 100 mM eosin Y 
• 1 mL of 1 vinyl-2-pyrrolidinone 99+% (NVP) 
In a glass vial, mix until total dissolution of the eosin Y. Store at 4°C. 
REMEMBER:  When using Eosin Y, dissolve PEGDA in a solution containing 
115mM Triethanolamine (TEAO). 
 
*NOTE: Before opening the NVP solution, be sure to allow it to warm fully to room 
temperature.  Before putting it away, it is very important that you inert the NVP 
stock by blowing argon into it. Parafilm the NVP and return it to the flammable 
refrigerator.  Parafilm your acetophenone solution, label and date it and place it in 
the flammables refrigerator. 
 
3. NOTE: 15 minutes prior to when you plan to expose your gel, you should turn on 
your light source to allow it to warm up and equilibrate to its final intensity.  Why?  
Because, lamps take time to reach their final intensity and the extent of 
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polymerization depends on the intensity of the light.  We quote the equilibrium light 
intensity in papers, so we should use it. 
4. Choose your desired solution volume in mL.  Weigh out 0.1 grams of PEG-DA per 
mL of this desired solution volume. (For each well of the plate, 1 mL solution is 
needed, so 0.1 grams of PEG-DA for each well and therefore 6 mL for each plate). 
5. Add the amount of PEG-DA you want to use to the 15 mL conical vial. 
6. Subtract the polymer weight from the total solution weight to get the amount of 
solvent+initiator that you will add.  For easy calculation:   
 
HBS+Initiator ( mL) = (0.9)×(desired solution volume in mL) 
 
(E.g., if you are making 10 mL of 10% PEGDA, then you have 1 gram of powder.  
Meaning that you will only need to add 9 mLs of HBS or HBS/TEOA since the 
powder has a volume associated with it). 
-For one Flexcell plate, to make a 6 mL solution, add 0.6 grams of PEG-DA and 5.4 
mL of HBS. 
 
HBS 
 
10 mM HEPES 
150 mM NaCl 
pH to 7.4 using 1N NaOH (you should use pH meter) 
 
 
HBS-Triethanolamine (HBS-TEOA) 
 
10 mM HEPES 
150 mM NaCl 
115 mM Triethanolamine (TEOA) 
pH solution USING pH paper to 7.4 using HCl 
 
 
7. Calculate amount of initiator solution that you need to add based off of the stock 
initiator solution concentration and the final initiator concentration that you want. 
Normally our stock solutions of each initiator are prepared so that we have to add 
10µLinitiator stock per mL total volume. 
 
Initiator ( mL) = (0.01)×(desired solution volume in mL) 
For micropipetting - (multiply by 1000 to get µL) 
 
8. Subtract the total amount of initiator stock from the amount of solvent+initiator 
required that was calculated in step 6 to get the amount of HBS OR HBS-TEOA 
that you will add. 
 
HBS ( mL) = (HBS+Initiator ( mL)) – (Initiator ( mL)) 
mL HBS = mL HBS TEOA 
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9. Add this amount of buffer to the PEG-DA in the conical vial, dissolve by 
vortexing.  Add photoinitiator.  Filter sterilize in the hood using a 0.22 um filter. 
10. If you are encapsulating cells, add the PEG-DA solution to a cell pellet that will 
give the desired cell concentration, suspend the cells by repeated pipetting.  Do 
not vortex. 
11. Polymerize PEG-DA solution under an appropriate light source. NOTE: UV light 
is absorbed by most plastics, so if you are encapsulating cells in a 48 well plate, 
you need to remove the lid during the 365 nm UV exposure phase.  Most gels will 
polymerize within 1-2 minutes.  Try to maintain your gelation times as standard 
as possible. 
12. If cells have been encapsulated, add media.  Place in incubator. 
13. Clean up your mess. 
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Appendix H:  Polydimethylsiloxane (PDMS) Protocol 
1. Mix base and curing agent at a ratio of 30:1 by mass with a wooden stick for 5 
minutes. 
To make 20 grams: mix 0.667 g curing agent and 19.333 g base. 
2. Mix base and curing agent at a ratio of 80:1 by mass with a wooden stick for 5 
minutes. 
To make 20 grams: mix 0.25 g curing agent and 19.75 g base. 
3. Degas the mixture for 20 minutes in a vacuum chamber to remove all air bubbles. 
4. Pour the prepolymer inside a 5 mL syringe. 
5. Add 1.1 mL to each appropriate well in the 6-well plates to create a 1 mm thick 
substrate. 
6. Place the 6-well plates on a level countertop to allow the substrate to flatten. 
7. Place the 6-well plates in a 60°C oven for 20 hours to allow the PDMS to cure. 
8. Allow PDMS to cool to room temperature. 
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Appendix I:  Setting up the FlexcellTM System 
1. Check all of the flexcell equipment: 
 Water trap (check water level DAILY) 
 Control unit 
 Hosing (attachments) 
Pump 
Pressure reservoir 
 
2. Liberally apply silicone lubricant to tops and sides of Delran posts on the base plate. 
3. Place the experiment plate and three “blank” plates on the base plate. 
4. Check seal and put the weight on the plates. 
5. Place the experiment base plate inside the incubator (37 degrees, 80-90% humidity, 
10% CO2). 
6. Place the control plate on a second base plate. 
7. Place the control base plate inside the incubator (37 degrees, 80-90% humidity, 10% 
CO2). 
8. Attach the experiment base plate to the system (blue to blue and white to white). 
9. Set up the flexcell program with the following settings: 
 Controller: FlexLink #3 
Baseplate: BFlx Loading Station (25mm) 
1 Hz 
5% or 15% Stretch 
duration:  2 days 
square wave 
DC: 50% 
 
10. Turn on the pump (green button). 
11. Turn on the pressure reservoir (yellow handle). 
12. Click start in the flexcell program. 
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Appendix J:  Plate Assembly 
 
Plate Disassembly Protocol 
1. Obtain a BioFlex® six-well culture plate (Flexcell™ Int.) 
2. Use a wedge and hammer to carefully separate each heat seal section between the 
wells of the top and bottom place pieces.  Be careful to not apply too much force, 
as this will crack the plate.  Discard the silicone membrane. 
3. Use a Dremel high-speed rotary tool to remove excess heat-sealed material on 
both the top and bottom plate pieces while smoothing each area. 
4. Use a Dremel to remove the four vertical corners of the top plate piece to allow 
placement of bolts, nuts, and washers in each corner. 
5. Place the two plate pieces back together and drill two 1/4-inch holes in the two 
center sections while aligning the hole placement with a Delran post plate (for 
proper plate alignment on the Flexcell diaphragm). 
6. Drill ten 9/64-inch holes in each section around the perimeter of the plate using 
washers for proper hole placement. 
7. Remove and excess material from the drilling process and wash the entire plate 
using detergent and warm water. 
 
Latex Preparation 
Prior to pre-stretching latex sheeting using the pre-stretch device, latex must be 
leached for a 24 hour period to remove proteins harmful to cells.  Cut one piece of 10 x 
10 inch, 0.014 inch thick latex for each plate (SmallParts Inc.).  Immerse each sheet in a 
glass dish filled with deionized water and lay flat using weights to hold down the edges.  
Make sure that water is touching both sides of each latex sheet (remove all bubbles).  
Rinse as often as possible (empty and refill glass dish with dionized water) for a period of 
3 days, then rinse with media for 1 day.  Let the latex dry before plate assembly. 
 
Latex Pre-Stretch 
 
1. Obtain the blue sewing ring pair 
2. Lay the inner blue sewing ring (without adjustment knob) on a flat surface with the 
lip side up 
3. Lay the latex sheet over the ring with the dull side up 
4. Lining up the blue, green, and black marks on both rings, place the outer blue ring 
over the latex and around the inner ring.  Push the outer ring so that it is flush with the 
inner ring (stretching the latex).  Keep the ring tight throughout this entire process by 
turning the adjustment knob.  Make sure that the outside ring is pushed below the lip 
of the inner ring. 
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5. Place the sewing rings and latex over the wooden part of the pre-stretch device lining 
it up using the blue, green, and black marks.  Insert an alignment nail through each 
ring into the wooden pre-stretch device in the pre-made holes. 
 
 
Plate Assembly 
 
1. Insert the bottom half of the plate (thinner piece) into the square hole in the bottom of 
the pre-stretch device.  Make sure that the smooth part of the plate is the side that is 
touching the latex. 
2. Turn the assembly bottom side up onto a hard surface so that the latex is on the 
bottom and the plate piece is on top.  Cut holes in the latex for bolts with a 2mm 
biopsy punch (Premier Products, Co.) using the previously drilled holes in the plate 
bottom for alignment. Make sure that the holes are big enough to allow clearance for 
the bolts. 
3. Place the top part of the plate on the other side of the latex membrane lining up the 
holes for the bolts.  Insert two 1/4-20 x 3/4 inch stainless Phillips truss head machine 
screws in the center holes with stainless steel bonded sealing washers and fasten 
using hex nuts (Fastenal Co.).  Insert 10 #6-32 x 3/8” stainless Phillips truss head 
machine screws in the remaining holes with corresponding stainless steel bonded 
sealing washers and hex nuts (Fastenal Co.). 
4. Once all bolts are tightened, disassemble the pre-stretch device and cut the excess 
latex away from the plate leaving about a ½ inch border. 
5. Make sure the plate is sealed by putting the assembled plate onto the Flexcell 
diaphragm.  Apply stretch and listen for leaks around each bolt using a tube.  Tighten 
bolts where necessary. 
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Appendix K:  Plasma Oxidation 
(using Plasma Prep II) 
 
Created by: Lee Sierad        v 1.0         4/26/2007 
 
1. Ensure that the “meter” switch is up and the other two switches are down. 
2. Turn on the Plasma Prep II (press the square red button on the front). 
3. Let the machine warm up for at least three minutes. 
4. Place hose coming from large vacuum pump (bottom of cart) into the side of the 
chemical hood. 
5. Turn on large vacuum pump. 
6. Turn on the O2. 
7. CAREFULLY remove sample container from device. 
8. Place sample inside of container. 
9. CAREFULLY replace sample container into device. 
10. Turn “vacuum” to on position (switch – up). 
11. Ensure a vacuum has been reached. 
 
Perform the next set of steps quickly so the sample is not under plasma oxidation for an 
extended period of time. 
12. Turn power on (switch – up). 
13. Turn level up so meter reads about 40. 
14. Tune counterclockwise until area becomes magenta. 
15. Turn level all the way up – about 100. 
16. Tune clockwise slowly until area is at its greatest intensity of magenta. 
 
17. Let sit for 30 seconds. 
18. Turn level all the way down.  
19. Turn power switch off. 
20. Turn vacuum switch off. 
21. Wait for vacuum to release. 
22. Remove the sample and IMMEDIATELY coat with 3-aminopropyltrimethoxysilane. 
23. Repeat steps 7 through 22 as needed for multiple samples. 
24. Turn large vacuum off. 
25. Turn O2 off. 
26. Turn Plasma Prep II off. 
27. Replace hose to bottom of cart. 
28. Follow Latex Activation protocol to finish activating the surface. 
 93
Appendix L:  Activation (Silanization) of Latex 
Created by: Lee Sierad        v 1.0         4/26/2007 
Modified from: Yu-Li Wang Laboratory’s Acrylamide Substrate Protocol 
 
1. Follow Plasma Oxidation protocol and plasma-oxidize latex plates for 30 seconds. 
2. Using a glass pipet, IMMEDIATELY cover bottom of each well with 3-
aminopropyltrimethoxy silane (about 6-10 drops). Spread over the entire area. 
3. Incubate at room temperature for 5 minutes. 
4. Rinse with Distilled water on a shaker for 20-60 minutes, changing the water 3 times 
(minimum) at room temp. (It is important to rinse well at this step, otherwise the latex 
will have a reddish tint after application of gluteraldehyde). 
5. Using a plastic transfer pipet in a chemical hood, cover the bottom of each well with 
0.5% gluteraldehyde. 
6. Incubate at room temperature for 30 minutes. 
Rinse with Distilled water on a shaker for 20-60 minutes, changing the water 3 times 
(minimum) at room temp. 
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Appendix M:  Attachment of O-Rings to Latex for 
Containment of Primary PA  
Created by: Lee Sierad        v 1.0         4/26/2007 
 
1. Wash o-rings with detergent. Rinse well and dry. 
2. Spread a thin layer of medical grade silicone adhesive on the bottom of a weigh dish. 
      (You will need to create alternate spreads upon need if the adhesive cures too fast) 
3. Push the o-ring into the adhesive with forceps or finger tips. 
4. With forceps, remove the o-ring from the adhesive and place on the bottom of a clean 
weigh dish. 
5. Press down with forceps of finger tips. 
6. With forceps, take the o-ring from the clean dish and place it in the center of the well. 
7. Push down on the o-ring to ensure a seal between the o-ring and the latex. 
8. After all the wells have o-rings, place the dished in a 60°C oven for 1 hour. 
9. Let cool to room temperature. 
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Appendix N:  Primary PA Layer Polymerization 
Created by: Lee Sierad        v 1.0         4/26/2007 
Modified from: Yu-Li Wang Laboratory’s Acrylamide Substrate Protocol 
 
Materials: 
• 1x PBS 
• ddH2O 
• HEPES 1 M, pH 8.5, 1 ml 
• Acrylamide (40%) and Bis (2%) (Biorad) 
• 2,2’-Azobis(2-methylpropionamidine) dihydrochloride, 97% (AIBN), 20 mg/mL 
Catalogue #440914 (Aldrich) 
 
1. Degas ~50mL ddH2O in a beaker for ~20 minutes. 
2. Mix 625 µL Acrylamide, 300 µL bis, 50 µL HEPES, and 4025 µL ddH2O in a 25 
mL glass beaker to make an acrylamide gel of acryl/bis concentration of 
5%/0.12% (approximately 33 kPa).  
3. Add 100 AIBN initiator and mix well by swirling. 
4. Lightly cover with foil, place beaker in vacuum jar, and degas solution for ~5 
minutes. NOTE: Depending on the strength of your vacuum, the solution may 
start to bubble over or freeze. If this happens, RELEASE THE VACUUM 
SLOWLY! 
5. Pipet 500 µL into the inside of each o-ring well. 
6. Place on a level surface and expose the acrylamide (not through the latex) to UV 
light (365 nm) for 3 minutes and 30 seconds. 
7. Submerge in 1xDPBS and use forceps to remove each o-ring. Do this carefully. 
Do not tear any part of the acrylamide gel or poke any holes through the latex. 
8. Rinse with 1xDPBS for 3 hours, changing the water every 30 minutes (this can be 
“titered” down). 
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Appendix O:  Secondary PA Layer Polymerization 
Ref:  
Leach, J. Neural Eng., vol 4, 26-34 (2007) 
Schnaar, Analy Biochem, vol 151, 268-281 (1985) 
 
Materials 
 
40% Acrylamide 
2% Bis-acrylamide 
10x PBS 
TEMED 
1N HCl 
1mg/ml solution of human plasma fibronectin in DI(need 100ul per 1ml batch) 
10mg/ml Acrylic acid NHS ester in DI (need 1ul per 1ml batch) 
100mg/ml aqueous solution of APS in DI (need 5ul per 1ml batch) 
DI 
Latex-bottom 6-well plates for flexcell with o-ring and primary PA layer 
 (see protocols for instructions) 
22mm round coverslips 
35mm Petri dishes 
2M glycine in PBS (sterile) 
Sterile PBS 
 
Methods 
 
See excel sheet “Calculations for preparing acrylic acid NHS ester PA gels” for 
calculating necessary volumes. 
 
For each 1ml of prepolymer: 
1. Mix: 
a.  75-350ul of 40% acrylamide (see chart below) 
b. 20-350ul of 2% bis-acrylamide 
c. 100ul of 10x PBS 
d. 2ul of TEMED 
2. Bring volume to 800ul with DI 
3. Adjust pH to 7.4 + 0.3 
4. Add 100-200ul of 1mg/ml human plasma FN 
5. 1ul of a freshly prepared aqueous solution of 10mg/ml acrylic acid NHS ester 
6. 5ul of a 100mg/ml aqueous solution of APS 
7. Bring volume to 1ml with DI and mix well 
8. Use 80ul per 22mm coverslip and let polymerize for 1hr at RT 
9. Flood surface with ~0.5ml glycine and remove coverslip by prying up with a 
sharp scalpel blade 
10. Place under UV light for 10 min to sterilize 
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11. Add ~2ml sterile glycine to each dish and incubate at room temp overnight to 
quench the unreacted NHS 
12. Place under UV light for 10 min to sterilize 
13. Remove glycine and do three quick rinses with sterile PBS 
14. Incubate in PBS for 10 min at room temp 
15. Remove PBS, let dry for 1.5 mins, and add 200ul of media (note: only apply 
media to the PA, try to avoid getting media on glass surrounding PA gel) and 
incubate for 45 min at room temp. 
16. Remove media, let dry for 1.5 mins, and add cells (I use 5000 cells in 200ul 
media). Again, only put the cell solution on the PA gel. 
17. Allow 1hr for cell attachment (in incubator) and fill dish with media (~3ml) 
 
Final Acryl/Bis 40% Acrylamide (ul) 2% Bis (ul) DI to bring vol to 800ul (ul) 
8%/0.1% 200 50 448 
8/0.08 200 40 458 
8/0.06 200 30 468 
8/0.05 200 25 473 
8/0.04 200 20 478 
8/0.03 200 15 483 
8/0.02 200 10 488 
5/0.12 125 60 513 
5/0.10 125 50 523 
5/0.08 125 40 533 
5/0.06 125 30 543 
5/0.05 125 25 548 
5/0.025 125 12.6 560.4 
3/0.1 75 50 573 
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  Mass vial 
(mg) 
Mass 
vial + 
chem 
(mg) 
Mass 
(mg) 
Volume 
DI (ul) 
AA NHS ester 
(10mg/ml) 
923.8 925.3 1.5 150 
APS (100mg/ml) 922 924.4 2.4 24 
          
Solution Volume 
(ul) 
    
40% Acrylamide 200     
2% Bis-acrylamide 40     
10x PBS 100     
TEMED 2     
DI 458     
1N HCl 15     
FN 100     
AA NHS ester 1     
APS 5     
DI 79       
 
 
 
To change the stiffness of the gels, use the table below.  
40% Acrylamide 
(ul) 
2% Bis-
acrylamide 
(ul) 
10x PBS 
(ul) 
TEMED 
(ul) 
DI (ul)
200 50 100 2 448 
200 40 100 2 458 
200 30 100 2 468 
200 25 100 2 473 
200 20 100 2 478 
200 15 100 2 483 
200 10 100 2 488 
125 60 100 2 513 
125 50 100 2 523 
125 40 100 2 533 
125 30 100 2 543 
125 25 100 2 548 
125 12.6 100 2 560.4 
75 50 100 2 573 
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Appendix P:  Cell Culture Protocols 
Cell Counting (all methods are to be performed aseptically unless otherwise noted) 
1. Determine total amount of cells needed as follows: 
cells
cm
cellswells
wells
cm 68400105.112
1
80.3
2
32
=×××  
      Accounting for loss: 
cellscellscells 7524068400)10.0(68400 =+  
2. Aspirate media from flasks. 
3. Add 12 mL Trypsin to each T-150 flask.  
4. Incubate (37 degrees, 80-90% humidity, 10% CO2) until cells are detached and are 
not in clumps (cells are floating in single cell units). 
5. Add 12 mL media to each flask to neutralize Trypsin. 
6. Put contents of T-150 flasks into conical tubes. 
7. Centrifuge for 6 minutes at 1.2 rpm.  
8. Aspirate all media from conical tubes (being careful not to disturb the pellet). 
9. Add 2 mL of media to each conical tube. 
10. Mix by pipetting up and down until the pelleted cells are completely dispersed in the 
media (~ 20 times). 
11. If starting with more than one tube, combine the contents of all the conical tubes and 
mix by pipetting. 
12. Pipet 100 μL from the middle of the tube and place into an eppendorf tube (does not 
need to be sterile). 
13. Add 100 μL Trypan blue to eppendorf tube. 
14. Add 10 μl to both sides of a hemocytometer and allow capillary action to distribute 
liquid. 
15. Count the number of cells in the 4 outer squares: Totals 1:____  2:____  3:____  
4:____ 
16. Calculate cell concentration (cells/ mL) as follows: 
mL
cells
squares
cells ______________102
4
_____ 4 =××   
• 2 is the dilution factor (1:1) from Trypan blue. 
• 104 is for the volume of the hemocytometer (µL/ mL). 
 
Note: The hemocytometer is not reliable unless you have a minimum of 200 cells 
counted. 
 
17. Ensure enough total cells are present as follows: 
 
cellsmediacellsmL
mL
cells __________________________________ =+×  
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Cell Seeding (all methods are to be performed aseptically unless otherwise noted) 
 
1. Take out 1,000,000 cells from media+cells using the following equation: 
 
cells
mL
cells
removedmL
______________000,000,1
_______ =  
 
2. Place removed media+cells into media to make a total of 10 mL media+cells. 
 
10 mL-_______ mL removed=_________ mL DMEM w/10% FBS to be added 
 
3. Take out 0.76 mL from dilution just made and add to 9.24 mL media to make 10 mL 
of a dilution of 7,600cells/ mL. 
4. Place 0.75 mL of 7,600cells/ mL (1.5x103 cells/cm2) dilution into each well. 
5. Ensure that there is no liquid along the rim of each well. 
6. Incubate (37 degrees, 80-90% humidity, 10% CO2) 24 hours (overnight) to allow cell 
attachment. 
7. Aspirate all media from each well. 
8. Carefully remove the o-ring from each well. 
9. Add 3 mL media to each well. 
10. Change media every two days (when on the flexcell equipment - press “pause”). 
 
Trypsinize and Passage of a Cell Line (all methods are to be performed aseptically unless 
otherwise noted) 
 
Materials: 
 
• Trypsin (0.05%  EDTA) 
• 50 mL or15 mL conical tubes (polypropylene) 
• Cell culture media (DMEM + 10% BCS +  P/S)  
• Flask(s) (x cm²) (polypropylene) 
• Incubator (37 ºC ± 1 ºC, 10% CO2) 
• Water Bath set at 37 ºC ± 1.0 ºC 
• Centrifuge with appropriate rotor and buckets and set at 1000rpm 
 
Procedure: 
• Warm the trypsin (0.05% EDTA) and culture media (DMEM, 10% + P/S) for 15 
mins at 37 ºC in water bath. 
• Get one culture dish from the incubator.  
        -note: not advisable to do > 4 at one time. 
• Aspirate the culture media with glass pasture pipette or 1 mL sterilized pipette.  
• Transfer trypsin (0.05% EDTA) into the flask 
o 5 mL for T75 flask 
o 8 mL for T150 flask 
• Put the dish into the incubator (37 ºC ± 1 ºC, 10% CO2); check frequently   
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• Observe the dish under the microscope to see any cells floating. Tap sides gently 
(no splash on lid) until cells round up. 
-NOTE: leave cells in trypsin for as little time as possible. Trypsin kills 
cells (protease activity). 
• Add the same amount of culture media (DMEM, 10% + P/S) into the flask as was 
added for the trypsin. This inactivates the trypsin. 
o 5 mL for T75 flask 
o 8 mL for T150 flask 
• Transfer the entire mixture into a 50 mL conical tube. 
        -e.g: 15 mL for 1 plate, 50 mL for > 2 plates. 
• Spin down cell @1000 rpm (150 ref) for 5-7 mins  
• Label a new flask while your cells are spinning. Be sure to include the date, cell 
line, passage number and your initials. 
• Resuspend cells with appropriate volume of culture media (DMEM, 10% + P/S) 
to get approximately 0.5 X10*6 cells/ mL. Break up pellet at bottom of conical by 
gently adding media. Carefully pipette up and down to resuspend. Avoid bubbles. 
        -e.g: 5 mL for 2.5X10*6 cells.                            
• Add the volume of culture medium (DMEM, 10% + P/S) that you will need 
minus the volume of resuspended cells depending on your usage of a T75 or T150 
flask, into a 50 mL conical tube.   
• Add cell suspension (~ 0.5 million cells) into the 50 mL conical tube. Pipet mix. 
• Add the TOTAL FINAL volume of cells + culture medium to the flask 
o 15 mL total for T75 
o 25 mL total for T150 
• Put flask(s) into the incubator (37 ºC ± 1 ºC, 10% CO2). 
• Aspirate and add fresh media every 2-3 days, DEPENDENT UPON THE CELL 
LINE!!!! 
• Passage the cells at 70-90% confluence.  
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Appendix Q:  Staining 
Staining with LIVE/DEAD Assay 
Created by: Lee Sierad        v 1.0         4/26/2007 
 
Materials: 
• Sterile 1x DPBS 
• LIVE/DEAD® Viability/Cytotoxicity Assay Kit (Molecular Probes) 
 
1. Make enough stain to keep cells moist according to the following recipe: 
 20 µL EthD-1 
 10 mL sterile DPBS 
 5 µL 4mM calcein 
 Vortex the EthD-1 and DPBS, then add calcein and vortex. 
2. Aspirate all culturing medium. 
3. Rinse cells once in warmed DPBS. 
4. Add 150 µL stain to each well. 
5. Incubate 35 minutes at room temp in the dark. 
6. Image using FITC and Texas Red filters to examine the cells. 
7. Take photographs with Spot Digital Analysis Software. 
 
 103
Staining with Hoescht and alpha-SMA 
Solution Preparation (all waste to be disposed of as Hazardous waste with the Formaldehyde unless 
otherwise noted) 
 
Prepare solutions as follows: 
• 3.7% Formaldehyde: 
1 mL 37% Formaldehyde + 9 mL ddH2O = 10 mL 3.7% Formaldehyde 
• 0.1% Triton: 
50 µL Triton + 50 mL ddH2O = 50 mL 0.1% Triton (extra to be used in 
future) 
 
Determine required amount of stain as follows: 
neededstaineachmL
well
mLwells 2.435.012 =×  
 
Fixing and Permeabilizing Cells: 
1. Aspirate media from the wells. 
2. Rinse one time with 2 mL 1x PBS.  Drain, but don’t dry. 
3. Place a new silicone o-ring in each well in the same position as the original o-
ring, reapplying silicone lubricant if necessary. 
4. Add enough 3.7% Formaldehyde to cover the substrate (approx 350ul). 
5. Incubate 10 min at room temp. 
6. Remove Formaldehyde and rinse one time with 2 mL 1x PBS. 
7. Add enough 0.1% Triton to cover the substrate (approx 350 ul). 
8. Incubate 5 min at room temp. 
9. Remove 0.1% Triton and rinse one time with 2 mL 1x PBS/BSA for five minutes 
three times. 
 
αSMA dilution (1:500): 
1. Dilute stock solution to 1:100 with 0.5% BSA in 1xPBS. 
• Add 495µL PBS/BSA to each 5µL aliquot to make a 1:100 dilution. 
2. Dilute 1:100 solution to 1:500 with 0.5% BSA in 1xPBS. 
• Add 0.5 mL 1:100 solution to 2 mL PBS/BSA to make 2.5 mL of 1:500 
dilution. 
3. Repeat until desired volume is acquired. 
 
αSMA staining: 
1. Add 0.35 mL αSMA stain to each well. 
2. Incubate 1 hour in the dark at room temperature. 
3. Rinse with 0.5% BSA/ 0.1%Tween/PBS two or three times. 
 
Hoechst staining: 
1. Add 20 µL of Hoechst stain to 6 mL ddH2O. 
2. Add 0.35 mL Hoechst stain to each well. 
3. Incubate 5 minutes at 37°C. 
4. Rinse with 0.5% BSA/ 0.1%Tween/PBS two or three times. 
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Appendix R:  Triad Analysis Protocol 
 
Image Capture: 
 
1.  Place markers on the material in a pattern centered in the middle of the culture well. 
 * use ink on dry rubber (latex, silicone) membrane 
 * use graphite shards on polyacrylamide substrate marker placement example: 
 
 
 
2.  Place the marked wells (in the Flexcell base plate) on a stable workspace. 
3.  Shroud the workspace with a curtain to prevent glare from extraneous light. 
4.  Mount a camera horizontally above the region of interest. 
5.  Use a circular fluorescent light to cast a soft uniform light on the well. 
 
For each plate: 
6.  Precondition by applying cyclic stretch for ~2 mins at ~40kPa 
 
For each well: 
7.  Apply static vacuum pressure, allowing sufficient time for the material to become 
stable (~30s). 
8.  Use a computer running SPOT Advanced Imaging software to control the camera and 
capture images for each level of static vacuum pressure applied (ranging from 0 kPa to 
~55 kPa). Save as uncompressed TIFFs  
 
 
Image Processing: 
 
Use ImageJ Analysis software (V 1.37) to determine the pixel coordinates of each marker 
within each of the captured images. To correct for minute shifts of the plate location 
within the image, determine the coordinates of the centroid of each well and subtract this 
from the coordinates of the centroids of each marker.  The specific procedure for this is 
outlined below. 
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ImageJ Protocol: 
 
Open Image J 
 - Set measurement preferences 
 Analyze > set measurements 
 Deselect all, select centroid 
 
For each image (one image per well per level of stretch) 
 
 - Open image in Image J 
 
 - Apply threshold 
 Image > adjust > threshold 
 Select "black & white" from the drop down menu 
 Adjust sliders to attain clear definition, record values 
*Apply exact same threshold values to all images of the same well 
 
 - Measure well centroid 
 Use wand (tracing) tool 
 Select in center of well 
 Analyze > measure 
 Copy measurement (x and y coordinates) 
 Paste into appropriate spreadsheet location 
 
- Measure each marker centroid 
 Use wand (tracing) tool 
 Select in center of marker 
 Analyze > measure  
 Repeat measurements for all markers 
  * Use identical order of measurement for all images 
 Copy measurements (x and y coordinates) 
 Paste into appropriate spreadsheet location 
  
Examples of an original image and an image with threshold are shown in Figure 44. 
 
Figure 44: Original image and image with threshold 
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Data Analysis: 
 
Select triangles for triad analysis.  Use MATLAB Programming Environment to create a 
program file and determine stretch in both x and y directions, as well as shear strain.  
Compare pixel coordinates of a set of three markers (triangle) before and after stretch, 
and calculate the change in linear distances in two dimensions.  This method can also be 
used in Microsoft Excel to simultaneously analyze and compute the strains for the desired 
number of triangles for analysis.  
 
The MATLAB mfile used in this project is shown below: 
 
%original coordinates% 
%p1% 
ox1=879; 
oy1=664; 
%p2% 
ox2=863; 
oy2=842; 
%p3% 
ox3=579; 
oy3=896; 
 
%moved coordinates% 
%q1% 
mx1=910; 
my1=646; 
%q2% 
mx2=-37.269; 
my2=-54.887; 
%q3% 
mx3=-5.929; 
my3=3.69; 
 
%distance between original points% 
odx12=ox2-ox1; 
ody12=oy2-oy1; 
 
odx23=ox3-ox2; 
ody23=oy3-oy2; 
 
odx31=ox1-ox3; 
ody31=oy1-oy3; 
 
%distance between moved points% 
mdx12=mx2-mx1; 
mdy12=my2-my1; 
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mdx23=mx3-mx2; 
mdy23=my3-my2; 
 
mdx31=mx1-mx3; 
mdy31=my1-my3; 
 
% 
o1dssq=(odx12)^2+(ody12)^2; 
o2dssq=(odx23)^2+(ody23)^2; 
o3dssq=(odx31)^2+(ody31)^2; 
 
m1dssq=(mdx12)^2+(mdy12)^2; 
m2dssq=(mdx23)^2+(mdy23)^2; 
m3dssq=(mdx31)^2+(mdy31)^2; 
 
%b% 
b1=m1dssq-o1dssq; 
b2=m2dssq-o2dssq; 
b3=m3dssq-o3dssq; 
 
b=[b1; b2; b3]; 
 
%A% 
a11=2*(odx12)^2; 
a12=4*(odx12)*(ody12); 
a13=2*(ody12)^2; 
 
a21=2*(odx23)^2; 
a22=4*(odx23)*(ody23); 
a23=2*(ody23)^2; 
 
a31=2*(odx31)^2; 
a32=4*(odx31)*(ody31); 
a33=2*(ody31)^2; 
 
A=[a11 a12 a13; a21 a22 a23; a31 a32 a33]; 
 
%[strain x; sheer; strain y]% 
x=A\b 
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Appendix S:  High Density Mapper (HDM) Protocol 
 
 
*Note:  Prior to using the HDM Software, save all images as .tif files.  Also, the HDM 
software compares two images at once by superimposing one image on top of the other.  
It is necessary therefore to make sure that the pictures are cropped if necessary for proper 
alignment. 
 
In HDM: 
 From the Start Menu:  All Programs → HDM → HDM.exe → File →Open.  In 
desired directory, select the two images for comparison by clicking the first image and 
holding down Ctrl to select the second image.  Then Open. 
 Use the mouse to select the desired rectangular region of interest, or type the 
desired pixel coordinates in the box shown below. 
 
Confirm the region of interest by clicking Set Region.  In the tool bar:  Correlator → 
Subimage Size → select the sub square size appropriate for analysis of the region of 
interest (i.e. 64 x 64 pixels – meaning that each data point will be made from a 64 x 64 
pixel square).  Then Correlator → Pixel Shift → select the pixel value to be used to 
shift the Subimage Size previously selected (i.e. 16 pixels – meaning that the 64 x 64 
pixel square will be shifted over 16 pixels for the following data point reusing some of 
the same data as the previous image through overlapping). 
 Lastly:  Correlator → Correlate.  Allow the HDM terminal to run until the text 
reads correlating…determining…shift is…finished. 
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 In Excel: 
For X Displacement Data: 
Make a new file and label the first cell (1A) U Displacement (Pixels).  Select the 
cell below the label and in the toolbar: Data → Import External Data → Import Data.  
Change the File of Type drop down menu to All Files.  Open the same folder from which 
the images being analyzed were opened in HDM.  Select the data labeled as filename1 + 
filename 2 _ U.dat → Open.  A Text Import Wizard box will appear on the Excel 
worksheet. Select Delimited → Next → unselect Tab and select Space → Next → select 
Do not import column (skip) → Finish → OK. 
For Y Displacement Data: 
 Skip a row after the U Data from above is inserted, and label the cell in the first 
column V Displacement (Pixels).  Using the same method for obtaining the U Data, 
open your V Data by opening filename1 + filename 2 _ V.dat. 
 Repeat this entire process for retrieving HDM data for comparing all stretch 
percentages.  For each well, use one Excel file labeling the file as “Data for Well x” with 
different sheets for each different stretch pair comparison. 
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Appendix T:  MATLAB Protocol for Smoothing HDM Data 
 
*Note:  This MATLAB Protocol involves taking the data retrieved from HDM Software 
and importing it into MATLAB for the purpose of 1) removing outliers from each 
column of the U Data by using the mean and standard deviation of each column to 
remove points outside the range of mean ± standard deviation, and removing outliers 
from each row of the V Data using the same method. 2) replacing each removed data 
point and replacing it with the mean of its respective column for U Data and respective 
row for V Data. 3) applying 2D smoothing using the desired box size 4) making color 
plots to reveal the range of values of the data. 
 
Prior to opening MATLAB software, save all data previously imported from 
HDM into Excel in separate files:  Using the mouse, highlight and copy one set of “U 
Displacement (Pixels)” data into a new excel document (do not copy the title).  Click 
File → Save As.  Change the Save as type drop down menu to Text (Tab delimited) 
and label the new file to save the document as a Text file for the MATLAB Software.  
For example, label the separated U Data as Wellx_2%-5%_U_Displacement and repeat 
the saving process and label the separated V Data as Wellx_2%-5%_V_Displacement.  
Save each file with the “Data for Well x” file in a folder to keep each text file with the 
original Excel file. 
 
In MATLAB (Setup): 
 From the Start Menu:  All Programs → MATLAB R 2006a → MATLAB R 
2006a.  In the toolbar, click Desktop → Editor.  In the Editor window, click the icon for 
“New M-File” .  Insert the following code: 
 
clear; clc;close 
  
fileName='Wellx_2%_5%_U_Disp.txt' 
data1=load(fileName); 
A=data1; 
dimMean=1; 
sizeBox=3; 
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meanA=mean(A, dimMean) 
stdA=std(A,0, dimMean) 
  
for i=1:size(A,2) 
    rowOut=find(A(:,i)>meanA(i)+stdA(i) | A(:,i)<meanA(i)-stdA(i)) 
    A(rowOut,i)=meanA(i); 
end 
  
filtA=medfilt2(A,[sizeBox sizeBox]); 
  
figure 
subplot(3,1,1) 
i1=image(data1) 
set(i1, 'CDataMapping','scaled') 
colorbar 
title('original image') 
  
subplot(3,1,2) 
i2=image(A) 
set(i2, 'CDataMapping','scaled') 
colorbar 
title('image - no outliers') 
  
subplot(3,1,3) 
i3=image(filtA) 
set(i3, 'CDataMapping','scaled') 
colorbar 
title('filtered image') 
  
figure 
subplot(1,2,1) 
rowNo=20 
plot(1:size(A,2), data1(rowNo,:),1:size(A,2), A(rowNo,:), 1:size(A,2), 
filtA(rowNo,:))  
legend('original data', 'no outliers', 'filt.data') 
  
subplot(1,2,2) 
colNo=10 
plot(1:size(A,1), data1(:, colNo),1:size(A,1), A(:,colNo), 1:size(A,1), 
filtA(:,colNo))  
legend('original data', 'no outliers', 'filt.data') 
  
dataMod=filtA(2:end-1, 2:end-1) 
figure 
i4=image(dataMod) 
set(i4, 'CDataMapping','scaled') 
colorbar 
title('Modified data set') 
 
Then in the toolbar, click File → Save As “U Data Analysis Code”.  Save this m-file 
into your “Data for Well x” folder (where each text file is). 
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 Repeat the above process and insert the following code for smoothing of the V 
Data and save as “V Data Analysis Code”. 
 
clear; clc;close 
  
fileName='Wellx_2%_5%_V_Disp.txt' 
data1=load(fileName); 
A=data1; 
dimMean=2; 
sizeBox=3; 
  
meanA=mean(A, dimMean) 
stdA=std(A,0, dimMean) 
  
for i=1:size(A,1) 
    colOut=find(A(i,:)>meanA(i)+stdA(i) | A(i,:)<meanA(i)-stdA(i)) 
    A(i,colOut)=meanA(i); 
end 
  
filtA=medfilt2(A,[sizeBox sizeBox]); 
  
figure 
subplot(3,1,1) 
i1=image(data1) 
set(i1, 'CDataMapping','scaled') 
colorbar 
title('original image') 
  
subplot(3,1,2) 
i2=image(A) 
set(i2, 'CDataMapping','scaled') 
colorbar 
title('image - no outliers') 
  
subplot(3,1,3) 
i3=image(filtA) 
set(i3, DataMapping','scaled') 'C
colorbar 
title('filtered image') 
  
figure 
subplot(1,2,1) 
rowNo=20 
plot(1:size(A,2), data1(rowNo,:),1:size(A,2), A(rowNo,:), 1:size(A,2), 
filtA(rowNo,:))  
legend('original data', 'no outliers', 'filt.data') 
  
subplot(1,2,2) 
colNo=10 
plot(1:size(A,1), data1(:, colNo),1:size(A,1), A(:,colNo), 1:size(A,1), 
filtA(:,colNo))  
legend('original data', 'no outliers', 'filt.data') 
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dataMod=filtA(2:end-1, 2:end-1) 
figure 
i4=image(dataMod) 
set(i4, 'CDataMapping','scaled') 
colorbar 
title('Modified data set') 
 
*Copy the folder containing the m-file and all text files to be analyzed in MATLAB to 
the desktop* 
 
In MATLAB (Data Analysis): 
 From the Start Menu:  All Programs → MATLAB R 2006a → MATLAB R 
2006a.  In the Current Directory tab, click the file folder icon  until one of the 
folders in the window below reads Documents and Settings.  Then double click 
Documents and Settings → your user name → Desktop.  Double click one m-file, i.e. 
“U Data Analysis Code”.  Enter in the file name of the text file you want to run through 
MATLAB in the top of the code where it reads: 
fileName='Wellx_2%_5%_U_Disp.txt'.  In the toolbar of the code window, Debug → 
Save and Run.  Wait for MATLAB to finish running. 
A total of three figures will automatically appear.  Figure 1 is a color map that 
shows the steps of data smoothing.  The top image shows the original data from HDM, 
the middle image is the HDM data with outliers removed and replaced with the means, 
and the bottom image is the HDM data after both the outliers removed (replaced with 
means) and 2D filtering.  The process of 2D filtering smoothes data by smoothing each 
specific data point using a box of surrounding points in the data set.  The average of these 
points and the specific data point itself replaces the specific data point.  The box size used 
for smoothing is shown in the code as sizeBox=3.  
Figure 2 is a cross section of the data after removing outliers (replacing with 
means) and filtering.  The plot on the left represents the row number data identified in the 
code (in this case “rowNo=20”).  The right plot in Figure 2 represents the column number 
of data identified in the code (in this case “colNo=10”).  Figure 3 is the data set after 
removal of outliers (replacing with means), 2D filtering, and modification.  The data is 
modified by taking the top and bottom row off the data set as well as the furthest left and 
furthest right column.  The command for this is shown above as 
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“dataMod=filtA(2:end-1, 2:end-1)”.  Since the numbers in this command are for a 
3x3 2D filter, the numbers must be adjusted if the size box for 2D filtering is changed 
(i.e. for 5x5 2D filter (box size 5), this command would read “dataMod=filtA(3:end-2, 
3:end-2)”.  If you wish to take off more data around the perimeter of your data set 
(recommended) change “dataMod=filtA(2:end-1, 2:end-1)” to the desired values.  
Save each figure as a JPEG image if necessary. 
 MATLAB displays the outliers removed in each column of the U Data by 
showing the row number of each column of the outlier.  The modified data at the end of 
this window shown in matrix of “column x to column y” represents the data set after the 
removal of outliers, insertion of the mean for the respective row, 2D smoothing, and 
removal of 1 data point around each edge of the original matrix (these points are now 
unreliable because they don’t have a complete set of surrounding points for 2D 
smoothing to occur). 
 
In Excel (To Determine Exx, Eyy, and Exy): 
 Open the file “Data for Well x” that contains U Displacement (Pixels) and V 
Displacement (Pixels).  Under the V Displacement data, skip one row, and label the first 
column in the next row down “U Displacement Smoothed”.  Using the mouse in the 
MATLAB window, highlight the modified data matrix at the end of the MATLAB 
window.  Copy the text  into the first column and first row under the “U Displacement 
Smoothed” label.  Click the paste options icon that appears  and click Use Text 
Import Wizard.  Select Delimited → Next → unselect Tab and select Space → Next 
→ select Do not import column (skip) → Finish → OK.  Repeat until each column is 
transferred into the excel document. 
 Skip one row at the end of the U smoothed data and label the next row and first 
column “V Displacement Smoothed”.  Repeat the In MATLAB (Data Analysis) process 
above using “V Data Analysis Code” and obtain figures and modified data for the 
modified V Displacement.  After the modified data is transferred into excel, the data is 
ready for calculations to determine the strain field. 
 Move down on row from the bottom of the smoothed V data and enter the 
numbers 0, 16, 32, 48, and 64 in the first 5 columns (for a 16 pixel shift).   Move two 
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cells over to column G and in 5 cells down type 0, -16, -32, -48, -64.  Move two cells 
down, and in the first column enter a label du/da (to compare movement of the u data to 
that of the actual pixels).  Below the title in the first column, input the equation 
=SLOPE(A#:E#, $A$#:$E$#), where A#:E# represents the first five U Displacement 
Smoothed points in the first row of data and $A$#:$E$# represents the row of 0, 16, 32, 
48, and 64 entered discussed above.  Expand the equation by dragging the lower right 
corner of the cell to fill the correct number of cells.  Since we’re using the slope of 5 
numbers at a time, the number of cells should have the same number of rows as the U 
Displacement Smoothed data and four columns less. 
 Move one row down from the bottom of the du/da data and label the cell in the 
first column du/db.  In the cell directly below this label, input the equation 
=SLOPE(A#:A#, $G$#:$G$#), where A#:A# represents the first five U Displacement 
Smoothed points in the first column of data and $G$#: $G$# represents the column of 0, -
16, -32, -48, -64 previously entered.  Expand the equation to fill the correct number of 
cells.  This data set should have four rows less than the U Displacement Smoothed data 
and the same number of columns. 
 Move one row down from the bottom of the du/db data and label the cell in the 
first column dv/db.  In the cell directly below this label, input the equation 
=SLOPE(A#:A#, $G$#:$G$#)$#), where A#:A# represents the first five V 
Displacement Smoothed points in the first column of data and $G$#: $G$# represents the 
column of 0, -16, -32, -48, -64 previously entered.  Expand the equation to fill the correct 
number of cells.  This data set should have four rows less than the V Displacement 
Smoothed data and the same number of columns (same size matrix as the du/db data). 
  Move one row down from the bottom of the dv/db data and label the cell in the 
first column dv/da.  In the cell directly below this label, input the equation 
=SLOPE(A#:E#, $A$#:$E$#), where A#:E# represents the first five V Displacement 
Smoothed points in the first row of data and $A$#:$E$# represents the row of 0, 16, 32, 
48, and 64 previously entered.  Expand the equation by dragging the lower right corner of 
the cell to fill the correct number of cells.  The data set should have the same number of 
rows as the V Displacement Smoothed data and four columns less (same size matrix as 
the du/da data). 
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Exx 
 Move one row down after the dv/da data and label the cell in the first column 
Exx.  To find the x strain data values, input the following equation into the first column 
of the next row: = du/da+0.5*((du/da)^2+(dv/da)^2).  The du/da and dv/da terms in this 
cell represent the corresponding du/da and dv/da terms (same row, same column) 
previously found.  Expand the equation by dragging this cell to fill the correct number of 
cells (the same size matrix as the dv/da data). 
Eyy 
 To find Eyy, move down a row after the Exx data and label the cell in the first 
column Eyy.  Input the following equation into the first column of the next row: = 
dv/db+0.5*((dv/db)^2+(du/db)^2).    The dv/db and du/db terms in this cell represent 
the corresponding dv/db and du/db terms previously found.  Expand the equation by 
dragging this cell to fill the correct number of cells (the same size matrix as the dv/db 
data). 
Exy 
 To fine the shear strain, move down a row after the Eyy data and label the cell in 
the first column Exy.  Input the following equation into the first column of the next row: 
=0.5*(du/db+dv/da+(du/da*du/db+dv/da*dv/db)).  Enter in the cell numbers being 
evaluated for the du/db, dv/da, du/da, and du/db terms.  Expand the equation by dragging 
this cell to fill the correct number of cells (the same size matrix as the original u or v 
displacement data with four rows less and four columns less). 
Statistics 
 To find the mean and standard deviation of Exx, enter: =AVERAGE(Exx 
matrix) and =STDEV(Exx matrix) into new cells.  To get “Exx matrix” into the 
equation, click the cell in the first row and first column of the Exx data and highlight the 
entire Exx matrix.  Repeat this procedure to find the mean and standard deviation of the 
Eyy and Exy data. 
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Appendix U:  SigmaPlot Protocol 
 
 * This software is to be used after both collection of data with HDM software as well as 
completed analysis using MATLAB® (Exx, Eyy, and Exy strain fields should be already 
calculated). 
 
From the Start Menu:  All Programs → SigmaPlot 9.0.  A window labeled “Data 1” 
will automatically appear.  Copy and paste one matrix of desired strain data for analysis 
(Exx, Eyy, or Exy) into this window, making sure that the data point in the first row and 
first column goes into row 1, column 1 in the “Data 1” window. 
In the toolbar: Graph → Create Graph.  In the “Create Graph – Type” window 
that appears:  Contour Plot → Next → Filled Contour Plot → Next → Many Z → 
Next.  In the “Selected columns” window, make sure that “First Z:” is highlighted.  In the 
Data 1 window, click the “1” box above the first column to highlight the entire first 
column of the data set.  Make sure that “Last Z:” is highlighted, and then highlight the 
last column of your data set.  Click Finish. 
The contour map will automatically appear in “spectrum” color fill.  To adjust any 
settings, including this color fill, double click the image to bring up the “Graph 
Properties” window.  To change the scale of the image, click the “Scale” button under 
“Settings for”.  Make sure that the “Apply to” drop down menu states Minor and then 
change the Start and End values in the “Range” section.  Use the “Graph Properties” 
window to change any other settings of the contour plot. 
To save the file:  File → Export.  Make sure that “Save as type:” drop down 
menu says JPEG (*jpg).  Adjusted settings if desired in the “Export JPEG file” menu → 
OK. 
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Appendix V:  Morphology Cell Measurements Protocol 
Source: Katie Bush 
 
1. Open Image J 
2. Open file in Image J 
3. Set measurements  
a. Go to Analyze 
b. Go to Set Measurements 
c. Make sure desired measurements are marked:  
i. Area 
ii. Circularity 
iii. Perimeter 
iv. Fit Ellipse (used for cell orientation) 
v. Feret’s Diameter (used for cell orientation) 
vi. Display label  
4. Use magnifying glass to make image larger 
5. Outline the cell’s perimeter using the heart trace tool (freehand trace) 
6. Get measurements 
a. Go to Analyze 
b. Measure 
7. Copy results into Excel 
The following steps are used for calculating cell orientation 
8. Return to Image J and set the yellow outline to permanent black outline 
a. Press Ctrl D to do so 
9. Add the Fit Ellipse 
a. Go to Edit 
b. Selection 
c. Fit Ellipse 
10. Press Ctrl D to change the yellow ellipse to black 
11. Look at the length of the Major Measurement on results table 
12. Using the line tool, draw the major axis of the fit ellipse 
13. Press Ctrl D to turn yellow line to black 
14. Using the angle tool, measure the angle between the major axis line and the 
crosslinked line 
15. Note the angle measurement on the Image J tool bar and record the angle in Excel 
16. Count the number of crosslinked lines that the cell crosses and record the number 
in Excel 
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Appendix W:  Aortic and Mitral VIC Isolation Protocol 
Source: Messier 1994, Taylor 2002, Butcher 2004 – also modified from personal 
experiences of Angela Throm 
 
Materials: 
• Collagenase (Worthington Collagenase, Type I (650 U/ mL) 
• Sterile PBS 
• DMEM + P/S (1 μg/ mL) 
• DMEM +10% FBS + P/S (1 μg/ mL) 
• Cell scrapers 
• Culture dishes 
• Nylon mesh conical tube filters 
• Sterile 15 mL conical tubes 
• Sterile scissors 
 
Collagenase Preparation: 
• Determine the volume of collagenase solution required for digestion. 
o Aortic valves (for up to 6 cusps) – 3 mL for endothelium digestion and 
(for up to 3 cusps) 3 mL for cell removal 
o Mitral valves (for up to 2 cups) – 3 mL for endothelium digestion and 3 
mL for cell removal 
• Calculate the mass of collagenase needed to make a 600 U/ mL solution. (the 
units/mg are batch specific and can be found on the collagenase bottle) 
ecollagenas
ecollagenas
solution Units
mg
ml
Unitsv ×× 600  
 
• Weigh out the collagenase and add to the appropriate volume of DMEM with P/S 
(NO Serum!!!) 
 
Valve dissection: 
• Remove mitral and/or aortic valves and place individual cusp types in beakers 
with 15 mL sterile PBS to rinse. Continue rinsing valves to remove blood.  
• Remove the cusps and place each cups type in a 15 mL conical tube with 3 mL 
collagenase (per 6 aortic cusps and 2 mitral cusps) 
• Place on rocker tray for 30 min at 37°C. 
• Rinse cusps in sterile PBS. 
• Place cusp in culture dish and scrape both sides with cell scraper to remove 
endothelial cells. 
• Rinse in sterile PBS. 
• Place rinsed cusp in new culture dish and mince into pieces approximately 1-2 
mm2  with sterile scissors or scalpel blade. 
• Place minced cusp in new 15 mL conical tube. 
• Add 3 mL of collagenase solution. 
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• Place on rocker tray for ~2 hr at 37°C or until valves are digested. You will need 
to keep checking the tubes so they don’t digest for too long. 
• Filter solution through nylon mesh into new 15 mL conical tube. 
• Centrifuge at 1.2X103 rpm and resuspend in DMEM +10% FBS 
• Perform cell count and plate. 
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Appendix X:  Triad Method Results 
 
Figure 45 through Figure 48 illustrate latex membrane stretch relative to vacuum 
pressure applied for each day of imaging analysis.  In each figure, stretch in both X and Y 
directions are displayed for every well. 
 
Figure 45:  Day 0 of latex membrane stretch 
 
Figure 46:  Day 3 of latex membrane stretch 
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Figure 47:  Day 5 of latex membrane stretch 
 
 
 
Figure 48:  Day 10 of latex membrane stretch 
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